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General Introduction 
Tracheobronchial clearance is defined as the sum of the effect of cough and muco­
ciliary transport. In normal circumstances mucociliary transport alone is sufficient 
with regard to clearance of the airways. When, for instance during respiratory tract 
infections, mucociliary transport is impaired cough may occur. Cough appears to be 
the most frequent complaint for which the general physician is consulted.1,2 Remedies 
for the treatment of cough belong to the most popular pharmaceutical preparations. 
When troublesome expectoration prevails treatment consists not only of drugs but 
quite often also of physical therapy aiming at mobilization of secretion. Many 
patients highly value these respective treatments. Objective evidence of clinical 
efficacy appears to be rather poor though. Parameters used for evaluation of the 
effectiveness have been lung function, blood gas analysis, frequency of exacerbations 
in chronic lung disease and especially scoring by the patients themselves. Because 
these treatment modalities are supposed to enhance the mobilization of secretion the 
most appropriate parameter for evaluation thereof seems to be the measurement of 
tracheobronchial clearance itself. In view of the need for more objective evidence 
whether or not several mucolytics and physiotherapy regimens were effective it 
seemed therefore obvious to us to use for this purpose the measurement of tracheo­
bronchial clearance. In 1967 Booker et al3 described a radio-aerosol technique for the 
in vivo measurement of tracheobronchial clearance in human beings. Thomson and 
Short4 reported the results of the measurement of tracheobronchial clearance using 
this technique in healthy subjects, in patients with chronic obstructive lung disease 
and with asbestosis. As of 1984 the measurement of tracheobronchial clearance using 
a technetium-99m ("Tc) labelled polystyrene aerosol was applied in the department 
of Nuclear Medicine in the University Hospital Nijmegen. 
To begin with a study was performed in order to assess variability of tracheo­
bronchial clearance in healthy subjects. The results of this study are described in 
chapter Π. 
Conventional physiotherapy consisting of postural drainage, chest percussion and 
instructed coughing has been the most frequently applied physiotherapy regimen 
during the last decades. A relatively new technique is the forced expiration technique. 
This includes breathing exercises, huffing and usually postural drainage. The forced 
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expiration technique has been advocated as being effective and more convenient than 
conventional physiotherapy especially for patients who require daily treatment.5 In 
chapter Ш the results of a study in which the conventional physiotherapy is com­
pared with the forced expiration technique are reported. 
More recently positive expiratory pressure mask breathing was reported as being 
a convenient and effective method for the mobilization of bronchial secretion.6 
Especially in centres for the treatment of cystic fibrosis this technique has become 
very popular. The effect of positive expiratory pressure on tracheobronchial clearance 
was investigated comparing this with the forced expiration technique. The results of 
this study are reported in chapter IV. 
Oral high frequency oscillation can be considered as an experimental technique 
originatmg from high frequency ventilation. As it seemed to be an elegant technique 
to enhance tracheobronchial clearance7 its efficacy in this respect was investigated 
and has been reported in chapter V. 
Quite often chest physical therapy is combined with the use of inhaled mucolytics. 
In order to be able to determine whether the effect of this type of treatment is due 
to its mucolytic action, its hypertonidty causing an osmotic reaction, or a simple 
wetting effect the study described in chapter VI was performed. An inhaled mu­
colytic, hypertonic or isotonic solution was combined with physiotherapy. Their 
effects on tracheobronchial clearance were compared with each other. 
Tracheobronchial clearance in a group of patients with dextrocardia is described 
in chapter VII. 
Finally in chapter Ш a study of the effect of sauna on tracheobronchial clear­
ance in patients with chronic bronchitis is reported. 
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Chapter I 
LI Tracheobronchial clearance, a brief survey of the literature 
1.1.1 Definitions 
Mucociliary transport is defined as the movement of mucus due to ciliary beating. 
Cough is another mechanism aimed at clearing the airways. It occurs usually when 
for some reason mucociliary transport is not sufficient. 
Tracheobronchial clearance is defined as the sum of the clearance by mucociliary 
transport and cough. 
Alveolar clearance is the mechanism by which the most distal airways and alveoli 
are kept clean. 
Whole lung clearance is commonly defined as the sum of tracheobrochial 
clearance and alveolar clearance. 
Three mechanisms play a major role in the deposition of particles in the airways. 
These are inertial impaction1,2, gravitational sedimentation2 and Brownian diffu-
sion.2 Minor mechanisms are electrical forces, thennophoresis and simple contact 
with the airway wall. The site of deposition of an inhaled particle depends on its 
physical and aerodynamic properties. This site determines to a large extend the 
mechanism through which the particle is removed from the airways. The airways 
extending from the respiratory bronchioli down to the alveoli are considered as the 
non-ciliated regions. These are kept clean mainly by means of phagocytosis. This 
clearance mechanism is referred to as alveolar clearance. In the remaining lower 
airways i.e. from the trachea down to the terminal bronchioli the lumen is lined 
with cihated epithelium. Under normal conditions here mucocihary transport is 
responsible for the removal of particles, excess secretion, cellular debris etc. Cough 
occurs under several pathological conditions among which impaired mucocihary 
transport. On theoretical grounds it is assumed that cough can only be effective in 
mobilizing secretion from the level of the trachea down to the 8th generation of 
Weibel's model of the lung.3 
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1.12. Normal structure and function of airway epithelium 
The epithelium lining the airways from trachea to terminal bronchioli consists mainly 
of two cell types. These are the ciliated cells and the goblet cells. There are some 
additional rarer cells, such as neuro-endocrine cells, which are capable of secreting 
certain mediators into the blood, and so-called brush cells, whose function is not yet 
understood. In the proximal airways there are approximately S ciliated cells to each 
goblet cell. The relative numbers of goblet cells and ciliated cells decrease towards 
the peripheral airways. It has been estimated that each ciliated cell contains about 
200 cilia. Tracheal dlia are 5-6 micrometer long and 0.2-03 micrometer in diameter. 
In the peripheral airways dlia are shorter. All normal dlia have nine pairs of 
peripherally located microtubules and two central microtubules.4 Bronchial mucus is 
mainly produced by goblet cells and submucosal glands. It consists for 95% of water. 
Apart from glycoproteins it contains also cells, debris and surfactant. It forms a fluid 
film lining the airway epithelium. In this fluid film commonly two more or less 
separate layers are distinguished, which are referred to as the sol and the gel phase. 
The sol phase is the periciliary layer. The gel phase is the outer more viscous layer, 
which the cilia reach only with their tips during the effective stroke of ciliary beating. 
The main macromolecular component of airway mucus are glycoproteins. Intra-
molecular and intermolecular disulphide bonds of glycoproteins are for a large part 
responsible for the gel structure of the outer layer. 
Relatively little is known about the regulation of secretion by the goblet cells and 
the ciliated cells. Irritants seem to play a major role here rather than neurohumoral 
or reflex mechanisms.1 The regulation of secretion by the submucosal glands is under 
parasympathetic and adrenergic control. Several phenomena induce an increase of 
secretion via vagal reflex pathways. For instance inflammation, hypoxia and gastric 
distension have been described as such.6 
1.13 Mucociliary transport 
Mucociliary transport can be considered as a non-specific host defence mechanism 
of the lung. Adequate ciliary motion and the presence of mucus are the prerequisites 
for mucociliary transport. Movement of the cilium is achieved by sliding of adjacent 
microtubular doublets. Ciliary beating consists roughly of two phases. These are the 
effective stroke and the recovery stroke. During the effective stroke the extended 
cilium reaches with fine daws on its tip into the gel phase thereby propelling it 
forward i.e. in the direction of the epiglottis. During the recovery stroke the cilium 
bends in the periciliary layer (sol phase) thereby sliding beneath the gel phase. Cilia 
beat at frequendes around 10-20 Hz. Within groups of dlia beating occurs in a 
coordinated fashion. This coordination not only implies that dlia beat in the same 
direction but also that dlia beat one after another causing a wave-like motion. Under 
normal conditions ciliary beating results in a mucus velodty of 0.5 mm/min in the 
peripheral airways gradually increasing centrally up to 15 mm/min in the trachea. 
The gel-like structure of airway mucus enables the transfer of energy from ciliary 
motion to the gel phase and is therefore essential for effective mucociliary trans-
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port.7,3 The quantity of mucus transported by the mucociliary escalator is estimated 
as ranging from 10 to 100 ml/24 hrs in healthy individuals.9 
1.1.4 Cough 
Cough is induced voluntarily or by reflex mechanisms via cough receptors. Cough 
begins with an inspiration. Then the glottis is closed. Expiratory muscles subsequently 
build up pressures up to 13 kPa or more in the airways. This compressive phase is 
followed by the expiratory phase when the glottis is opened abruptly. Cough can only 
be effective in mobilizing secretion from the level of the trachea down to the 8th 
generation of Weibel's model of the lung.3 The effectiveness of cough is closely 
related to the peakflow achieved during the expiratory phase as well as the duration 
thereof. Furthermore the viscoelastic properties of airway mucus are of importance. 
L2 Tracheobronchial clearance and disease 
1.2.1 Chronic bronchitis 
According to the MRC chronic bronchitis is defined as chronic or recurrent increase 
in the volume of mucoid secretion sufficient to cause expectoration on most days, 
for at least three months of the year, over two successive years.10 Smoking is con-
sidered to be the most frequent cause of chronic bronchitis. Hilding suggested that 
mucociliary dysfunction is the first abnormality in chronic bronchitis.11 Mucociliary 
transport has been demonstrated to be impaired in patients with chronic bronchitis.12 
Airways obstruction is a common feature in longstanding chronic bronchitis. There 
appears to be no relationship between impairment of mucociliary clearance and the 
degree of airways obstruction though.9 In chronic bronchitis the following structural 
changes in the mucosa have been described: hypertrophy and hyperplasia of sub-
mucosal glands, change in distribution and increase in number of goblet cells, loss 
and abnormal regeneration of cilia, edema and infiltration of the mucosa with 
inflammatory cells.13 The presence of excess mucus predisposes to colonization of the 
lower airways with pathogens and eventually to overt respiratory tract infections 
leading to further impairment of mucociliary clearance.14 
1.2.2 Asthma 
In mild stable asthma mucociliary transport has been shown to be impaired.15 Even 
in asymptomatic asthmatics tracheal mucus velocity appeared to be decreased.16 
Certain qualitative changes in mucus in asthmatics could have a negative effect on its 
rhéologie properties.17 Also it has been shown that e.g. antigen inhalation18, certain 
leukotrienes19 and histamine20 cause an increase in mucus production. Both these 
changes and epithelial damage inevitably lead to mucociliary dysfunction. Postmortem 
studies in patients who died in a status asthmaticus have revealed extensive des-
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quamation of the bronchial mucosa with widespread mucous plugging of small 
airways.21,22 So in severe asthma the mucociliary apparatus seems to be seriously 
damaged. 
1.23 Cystic fibrosis 
Structural abnormalities in the lungs of patients with cystic fibrosis are: hypertrophy 
of submucosal glands, goblet cell metaplasia, and mucous plugging of peripheral 
airways.23 Once there exists a persistent infection of the lower airways destruction of 
epithelium and squamous metaplasia occurs. 
Eventually bronciectasis and airways obstruction develop. Tracheobronchial 
clearance has been shown to be impaired. In one study a relation between the degree 
of impairment of tracheal mucus transport and the Schwachman score, an index for 
clinical condition, has been reported24, while others have been unable to confirm 
this.23 Although it is a widely accepted view that the viscosity of bronchial secretion 
is increased in cystic fibrosis no study dealing with the rhéologie properties of mucus 
has confirmed this.26"27,28 Since Spock et al29 reported the existence of a cilio-inhibitory 
serum factor in cystic fibrosis this finding still awaits final proof. 
1.2.4 Primary Ciliary Dyskinesia 
In 1933 Kartagener described four patients with the combination of situs inversus, 
sinusitis and bronchiectases.30 This is referred to as Kartagener's syndrome. Earlier 
the bronchiectases in these patients were thought to be congenital. Today it is a 
widely accepted view that they are caused by recurrent purulent respiratory tract 
infections.31 Kartagener's syndrome appeared to be associated to a high degree with 
infertility, although there have been reports of Kartagener patients with descend-
ants.3"5 Reports of sperm tail immotility focused attention on ciliary abnormalities 
as a possible cause of recurrent pulmonary infections.36 Since 1976 several specific 
abnormalities in the ciliary ultrastructure associated with ciliary immotility or 
dyskinesia have been reported.37-43 However Kartagener patients with normal cilia 
have also been described.44145 In conclusion there appears to exist a whole spectrum 
of congenital ciliary abnormalities of both structure and function in patients with and 
patients without situs inversus. Today this syndrome is reffered to as primary ciliary 
dyskinesia.46 Despite the absence of an important host defence mechanism patients 
with this syndrome, patients with Kartagener's syndrome included, appear to have a 
relatively good life expectancy. 
T.2.S Respiratory infections 
In naturally acquired common cold the mucociliary transport rate appears to be 
impaired up to 32 days after the first symptoms.47 In influenza A infections mucocil-
iary clearance was reduced for 3 months.4" Impairment of mucociliary transport is 
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probably caused by loss of and/or damage to ciliated cells. Furthermore an increase 
in bronchial secretion with abnormal rhéologie properties may add to mucociliary 
transport failure. In bacterial infections of the lower airways there is abo generalized 
mucociliary dysfunction, for which several mechanisms are responsible. Not only 
bacterial products but also proteases from leucocytes cause epithelial damage.49 
Several bacteria (Pseudomonas aeruginosa, Haemophilus influenzae, Bordetella 
pertussis and Streptococcus pneumoniae) also produce factors which have been 
shown to reduce ciliary beat frequency in vitro.5"3 
L3 Measurement of tracheobronchial clearance 
The mucus flow in the bronchial tree can only be measured using marker(s) of the 
mucus layer. Markers which have been used amongst others are: teflon discs, bismuth 
coated radiopaque discs, tantalum powder, radiolabelled albumin microspheres, and 
several types of radio-aerosol (teflon, albumin aggregates, iron oxide, erythrocytes, 
resin and polystyrene). 
There are several techniques to monitor the displacement of the marker(s) caused 
by tracheobronchial clearance. Direct visualization can be achieved by means of a 
bronchoscope. Less invasive external measurement can be performed using roentgen-
ographic equipment in case of radiopaque marker(s), scintillation detector(s) and 
gamma camera(s) after instillation or inhalation of radioactive marker(s). 
The main techniques to assess mucus transport, of which some are still in use 
nowadays are the following. For the cinebronchofiberscopic technique24, described 
in 1973, ten to twenty small teflon discs are blown into the trachea through a 
bronchoscope. Tracheal mucus velocity is calculated by measuring the time needed 
for the discs to move over a certain length. An alternative to this method implies the 
coating of the discs with a radiopaque substance (bismuth trioxide) and monitoring 
the displacement roentgenographically.5* This technique was reported in 1978. In case 
of the radionuclide bronchoscopic technique*5 (1979) about 40 μ 1 of a suspension 
containing albumin particles (5-7 μ m in diameter, labelled to technetium-99m) is 
deposited near the carina by a catheter inserted through a bronchoscope. Movement 
of the particles is recorded by means of a gamma camera for half an hour. The 
techniques mentioned above all have the disadvantage of being rather invasive, thus 
disturbing normal physiological conditions. Yeates et al described in 1975 the radio-
aerosol boli technique.57 By inhalation at high flow and at near total lung capacity a 
bolus of aqueous aerosol of albumin microspheres with a median diameter of 0,5 μ m 
and labelled with " T c is deposited in the central airways. A gamma camera is used 
for recording. This technique allows measurement in the central airways only. 
In contrast to this method the radio-aerosol technique in general implies the 
inhalation of a radio-aerosol resulting in deposition along the whole bronchial tree. 
Inevitably some particles penetrate into the so-called non-ciliated regions of the lungs 
consisting mainly of alveoli. This is usually referred to as alveolar deposition. After 
inhalation intrathoracic activity is monitored by means of several types of external 
detectors. Gamma cameras with a parallel hole collimator allow assessment of the 
initial radio-aerosol distribution and of regional clearance when serial images over 
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time are made.58 Relatively high amounts of radioactivity are required for this type 
of recording though. Integral counting of intrathoracic radioactivity with a sodium-
iodide detector with a wide angle collimator has a relatively high efficiency compared 
to a gamma camera. Therefore less activity is needed to obtain adequate statistical 
information. Two axially opposed detectors placed in front of and behind the subject 
enable the correction for movement of radioactivity towards or away from a de-
tector.9 Using this type of detectors it is important to apply such collimation that 
activity present in the throat or stomach is not counted effectively. The recording of 
the count rate over the chest at several points of time after inhalation provides 
information about the tracheobronchial clearance. The most important advantage of 
the radio-aerosol technique is its non-invasive character. Thereby it is possible, as 
mentioned above, to perform the measurement under physiological conditions. 
Another advantage is the small amount of radioactivity needed thus resulting in a low 
radiation dose to the lungs. Finally it comprises the clearance in all ciliated airways. 
Disadvantages of the radio-aerosol technique are the artefacts due to different 
deposition patterns and to cough. 
Advantages and disadvantages of the several techniques are listed in table 1. 
Table 1 
Technique Advantages Disadvantages 
Cinefiberscopic 
Roentgenograpic 
Radionuclide 
Bronchoscopic 
1. short observation 
period 
2. repeat measure-
ments within a 
short period of 
time 
3. measurement of 
clearance in well 
defined airways 
1. invasive 
2. limited to large 
airways only 
Radio-aerosol boli 1. non invasive 1. low sensitivity due 
to slow transport 
rates 
Radio-aerosol 1. non invasive 
2. low radiation dose 
3. measurement of 
clearance from all 
dialed airways 
clearance depends 
on deposition pat-
tern 
long observation 
periods (up to 24 h) 
artefacts due to 
coughing 
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L4 Outline of the study 
According to the technique described by Thomson and Short60 a similar radio-aero­
sol technique was developed in the department of Nuclear Mediane of the Univer­
sity Hospital Nijmegen. For repetitive measurement of clearance it is essential to be 
able to realize a similar deposition pattern. Therefore the aerosol should preferably 
be monodisperse. The aerosol which was used in our department contained " T c 
labelled polystyrene particles. This aerosol was produced by means of a spinning top 
generator (R.E. May Spinning Top Aerosol Generator, Research Engineer Ltd.). 
Mean particle diameter was 5 μ m (GSD = 0,80). Particle size, shape and presence 
of aggregates were checked regularly by examining slides left on the bottom of the 
aerosol tank, using a light microscope at a magnification up to 650 times. Not only 
the aerosol itself but also the inhalation procedure should be standardized. The 
equipment to achieve this was designed and built by the Department of Instrumenta­
tion of the medical faculty. A spirometer was linked in series to the tank in which the 
aerosol was produced, from which it was inhaled (see figures 1 and 2). 
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Figure 1. Schematic diagram showing the radio-aerosol inhalation unit. 
(a) tank with aerosol generator, (b) spirometer, (c) niter, (d) recorder, (e) valve. 
Thus it was possible to adjust the volume of the inhalations, aiming at 500 ml, and 
also record the flow of the inhalations. The inhalation procedure was as follows. To 
begin with the valve between subject and aerosol tank was shut and the subjects were 
breathing room air. At the end of an expiration, the valve between subject and 
aerosol tank was opened, while simultaneously the tube, through which the subject 
was breathing room air, was closed. After inhalation of the preset volume of radio-
aerosol the valve between subject and aerosol tank was closed automatically. Then 
followed a 3-second breathhold. Subsequently the connection with the room air was 
opened and the subject was instructed to expire first, after which room air breathing 
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Figure 2. Radio-aerosol inhalation unit in the department of Nuclear Medicine of the University 
Hospital Nijmegen. 
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Figure 3. 
activity. 
Subject positioned between the dual probe for the integral measurement of intrathoracic 
was resumed. This proce­
dure was repeated up to 10 
to 15 times, depending on 
the concentration of radio­
activity in the aerosol. The 
subjects were instructed 
and trained to inhale at 
tidal breathing level. After 
inhalation of the radio-
aerosol mtrathoracic activ­
ity was measured at regular 
intervals by means of a 
dual probe system (see 
figure 3). For the calcula­
tion of the tracheobronchial 
clearance the decrease in 
intrathoracic activity must 
be corrected for alveolar 
deposition (see figure 4). 
Because the physical half-
life of the radionuchde 
""Tc is only 6 hrs a corree-
100-, 
Percentage of 
Initial 
intrathoracic 
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Figuur 4. (a) Diagrammatic curve showing lung retention follow­
ing inhalation of radio-aerosol; (b) Curve showing tracheobron­
chial retention i.e. lung retention after correction for alveolar 
deposition. 
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tion for decay has to be made. The amount of activity expressed as percentage of 
initial activity is plotted against time after inhalation. In this way a tracheobronchial 
clearance curve or rather retention curve is calculated. A potential artefact in this 
type of measurement is the release of the radionuclide from the aerosol particles fol­
lowed by clearance across the bronchial mucosa. However the procedure to label 
polystyrene particles with " T c results in a low leaching tendency, i.e. less than 5% 
in 24 h.61 
The analysis of tracheobronchial clearance curves can be done in several ways.7 
One method is to fit the regression line to the observed data plotted on semilo-
garithmic paper. The slope of this line has been used as index of mucociliary 
clearance. Other parameters used are the amount cleared at a certain time after 
inhalation, the time needed for clearance of 50% of the initial activity and the area 
under the clearance curve. 
It was necessary to see whether the measurememt of tracheobronchial clearance as 
developed in our department showed sufficient intrasubject reproducibility. Therefore 
tracheobronchial clearance was measured twice in ten healthy non-smoking subjects. 
The results of our measurements appeared to be better than those reported by 
others using different techniques (see chapter Π). Studies in which the measurement 
of the tracheobronchial clearance is used, should preferably be of the cross-over type 
because of the rather large intersubject variability. On the basis of our study and 
that of Del Donno et al62 it is possible to determine the required number of subjects 
or patients needed to demonstrate a certain effect in a cross-over study (see discus­
sion chapter II). Beforehand the minimum change in tracheobronchial clearance 
which is considered as being of clinical relevance must be determined. 
After the evaluation of the variability of tracheobronchial clearance several studies 
were performed to assess the efficacy of several types of physiotherapeutic interven­
tions. For these studies the randomized cross-over design was chosen. In the first 
study (chapter ΙΠ) the effect of conventional physiotherapy on tracheobronchial 
clearance was compared with that of the forced expiration technique combined with 
postural drainage. The aim of the study was to compare efficacy of both treatment 
regimens as applied in daily practice. The patients participating in this study all 
required regular chest physical therapy. Also the design of the study was such that 
common every day practice was mimicked as closely as possible. Apart from the 
effect on tracheobronchial clearance regional lung clearance was evaluated as well. 
For this purpose gamma camera images were recorded before and after treatment. 
Since the results of this study clearly showed the efficacy of the forced expiration 
technique combined with postural drainage, this physiotherapeutic regimen was 
chosen in subsequent studies as standard chest physical therapy. In chapter IV the 
effect of positive expiratory pressure mask breathing, a relatively new method of 
physiotherapy, on tracheobronchial clearance and regional lung clearance was studied 
and compared with the forced expiration technique combined with postural drainage. 
In contrast with the study mentioned above (chapter Ш), in this study a control 
measurement was included. For this study patients with chronic bronchitis with 
abundant sputum production were selected. The same type of patients were included 
in studies to evaluate the effect of oral high frequency oscillation (chapter V) and of 
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several aerosols inhaled prior to a forced expiration technique session including 
postural drainage (chapter VI). In view of the increasing number of conflicting 
reports on patients with primary ciliary dyskinesia the study described in chapter VII 
reporting the results of the measurement of tracheobronchial clearance in patients 
with dextrocardia was performed. Efforts were made to correct for the effect of 
cough in order to determine the amount of effective mucociliary transport in these 
patients. Furthermore these patients and, in general, patients with the primary ciliary 
dyskinesia syndrome quite often receive chest physical therapy. The results described 
in chapter VII should add to the understanding of the efficacy of cough and/or 
physiotherapy in this kind of patients. 
Patients with chronic bronchitis reported a subjective enhancement of expectora­
tion during and directly after sauna to such an extend that it might even replace chest 
physical therapy. Therefore a study was undertaken to investigate the effect of sauna 
on tracheobronchial clearance in chronic bronchitics (chapter ПІ). 
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healthy non-smoking subjects 
M. van Hengstum*, J. Festen*, W. Buijs**, W. van den Broek**, F. Carstens** 
*Dept. of Pulmonary Düeases, **DepL of Nuclear Medicine, University Hospital 
Nijmegen, the Netherlands 
Respiration 1989;56:94-102 
KEY WORDS: Variability; Reprodudbility, Mucociliary dearance; Tracheobronchial 
clearance; Area under the curve 
ABSTRACT 
Tracheobronchial dearance was measured twice in 10 healthy non-smoking volun-
teers to evaluate inter- and intrasubject variability, using a radio-aerosol technique (5 
μ m T c labelled polystyrene partides). By means of two detectors radioactivity in 
the lungs was measured at regular intervals for б hours and once more 24 hours after 
inhalation. The decrease in radioactivity after correction for background activity, 
isotope decay and 24-hour retention was assumed to reflect tracheobronchial 
dearance. Among other parameters to quantitate the results of these tests, the area 
under the retention curve up to 6 hours after inhalation (AUC-6) was calculated. The 
intersubject coeffident of variation (COV) using the AUC-6 was 31%. The intra­
subject COV of the AUC-6 was 11%. These results compare favourably with those 
reported by others using different techniques. It is conduded that the intrasubject 
variability of tracheobronchial dearance as measured by this technique is small. 
M. van Hengstum, Afdeling Longziekten, University Hospital Nijmegen, Geert Groote­
plein Zuid 8, p.o. bac 9101, 6500 HB Nijmegen, The Netherlands. 
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Introduction 
Several methods and techniques to measure tracheobronchial clearance have been 
described1'5. Only few studies have focused on the variability of the results of these 
measurements6'11' There is no study on the intrasubject variability in healthy subjects 
of tracheobronchial clearance as measured by means of the non-invasive radio-
aerosol technique developed by Thomson and Short4. The aerosol which they used 
contained 5 μ m tetraphenylarsonium pertechnetate labelled polystyrene particles. 
Polystyrene has the advantage of being biologically inert and non-hygroscopic as well 
in contrast to, for instance, albumin microspheres or erythrocytes. The procedure to 
label these particles with " T c results in a low leaching tendency, i.e. less than 5% 
in 24 hours12. 
In order to be able to evaluate the effects of various physiological factors and of 
medication on tracheobronchial clearance in healthy non-smokers, the inter- and 
intrasubject variability as measured by this technique, have to be known. Tracheo­
bronchial clearance was therefore assessed on two occasions in healthy non-smoking 
volunteers. 
Methods 
The method used has been described by Thomson and Short4. T c as tetraphenyl­
arsonium pertechnetate was dissolved in a polystyrene solution consisting of xylene 
and methylisobutyl ketone. This solution was fed to a spinning top generator 
(R.E.May Spinning Top Aerosol Generator, Research Engineer Ltd) rotating at such 
a speed that droplets were produced which, after evaporation of the solvent, left 5 
μ m particles (GSD = 0.80). On average this solution contained 14 mCi (518 MBq). 
The aerosol was produced in a 90 Utre airtight tank. The subjects inhaled from this 
tank, which was linked in series with a wet spirometer (Pulmotest-Godart), by which 
the average flow of the inhalations (Le. volume inspired/time for inspiration) was 
registered and their volume controlled, aiming at 450-500 ml. After each inhalation 
there was a 3-second breathhold. The number of inhalations in each test varied, 
depending on the estimated concentration of radioactivity in the aerosol. After the 
inhalations were completed, the subject was instructed to gargle and rinse the mouth 
in order to remove activity deposited there. 
Particle size, shape and presence of aggregates were checked regularly by 
examining slides left on the bottom of the aerosol tank, using a light microscope at 
a magnification up to 650 times. 
The radioactivity in the thorax was measured by means of two horizontally 
opposed scintillation detectors (2 inch Thallium activated Nal crystals). One detector 
was placed in front of the seated subject and centred midway the sternum, and the 
other behind the subject and centred at the spmal column. Interference of activity 
present in stomach or throat with the measurement of activity present in the lungs 
was reduced to a minimum by using collimators with an aperture of 9.0 cm diameter 
at 2.5 cm from the crystal. Before each measurement the subject was asked to drink 
some water to remove radioactivity present in the oesophagus. The contours of the 
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detectors were marked on the skin for reproducible repositioning. Radioactivity was 
measured for 90 seconds at regular intervals during 6 hours, starting immediately 
after inhalation. The number of measurements per test averaged 16. Radioactivity 
was measured for 5 minutes at 24 hours after inhalation. This measurement was 
supposed to be an estimate of radio-aerosol deposition in the non-dliated regions of 
the lungs. The sum of the radioactivity counts of the two detectors was corrected for 
background activity, isotope decay and 24-hour retention. The tracheobronchial 
retention curve was obtained by expressing the corrected counts as percentage of the 
number of counts in the first measurement after inhalation and plotting that against 
time after inhalation. In every individual retention curve the percentages at each 
20-mmute interval were interpolated and used to calculate the mean of the tracheo­
bronchial retention curves of the groups as a whole. The percentages of initial activity 
cleared at 2,4 and 6 hours after inhalation of the radio-aerosol were also calculated 
by interpolation of the tracheobronchial retention curves. The area under the 
retention curve up to 2 (AUC-2), 4 (AUC-4) and 6 hours after inhalation (AUC-6) 
was calculated using non-fitted data and expressed in % hours. 
Two-way analysis of variance (ANOVA) was applied to detect a systematic 
difference between the first and second test. One-way ANOVA was applied to 
evaluate intra- and intersubject variation for each method of clearance assessment. 
The results are expressed as coefficients of variation (COV). 
Wilcoxon's test for paired data was used to evaluate the significance of any 
differences observed. 
As described by Hills and Armitage13 we calculated the number of subjects 
needed to be included in each limb of a cross-over design study, in order to detect 
given differences at ρ < 0.05 with various probabilities of success (power). For this 
the following formula was used: η = (A2 χ SO/)/(2 χ D2) where, A = (actual 
difference)/(standard error) varying for different powers; SDd = standard deviation 
for the paired differences between the two measurements of the cross-over study; 
D = expected mean differences between the two measurements. The power of a trial 
is defined as the probability that the trial will produce a difference between treat­
ments which is significantly different from zero at a certain statistical level of 
significance (usually taken to be 5%)°. 
Since the cross-over study design usually consists of two limbs the total number 
of patients necessary for such a study was taken as twice that given by the above 
formula, i.e. 2n. 
The tracheobronchial clearance was measured twice under identical conditions. In 
order to avoid possible diurnal variation in each subject tracheobronchial clearance 
was measured at the same time of the day. The median interval between the two 
tests was 13 days, ranging from 7 to 210 days. 
Subjects 
Ten healthy non-smoking male volunteers took part in the study. Individual data are 
listed in Table 1. They did not take any medication. There was no history of recent 
respiratory tract infection. 
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Lung function tests were performed in all subjects. Results are listed in Table 1. 
The mean ratio FEVj/FVC% was 82%, which was 106% of the predicted value. 
The subjects were informed about the design and the aims of the study. Written 
informed consent was obtained. 
The study was approved by the Medical Ethics Committee of the hospital. 
Results 
Data concerning the inhalations are listed in Table 1. In two subjects the amount of 
inhaled radioactivity was measured by means of a whole body counter and appeared 
to be 0.02 mCi (740 kBq). The estimated effective dose equivalent was 0.09 mSv 
( = 9 mrem). 
Table 1. Data on age and lung function of the subjects, flow and volume of the 
radio-aerosol inhalations, and 24-hour retention. 
Subject 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Age 
46 
31 
24 
22 
23 
25 
22 
22 
26 
27 
Mean 27 
SD -
Lung function 
% predicted 
FVC 
119 
119 
81 
114 
100 
99 
97 
125 
115 
109 
108 
13 
FEV1 
125 
120 
98 
124 
103 
105 
97 
120 
175 
120 
114 
12 
mean 
Inhalation 
volume 
ml 
I 
454 
439 
480 
570 
496 
560 
456 
442 
442 
477 
482 
48 
Π 
488 
468 
532 
508 
488 
595 
505 
463 
462 
463 
497 
42 
mean flow 
1/min 
I 
28 
62 
67 
62 
65 
87 
59 
60 
47 
47 
58 
15 
Π 
37 
65 
78 
76 
79 
91 
75 
_· 
50 
44 
66 
18 
24-hour 
retention 
(%: inifial 
activity) 
I 
67 
54 
46 
66 
38 
45 
46 
60 
53 
58 
53 
10 
Π 
67 
58 
48 
55 
49 
36 
33 
53 
59 
55 
51 
10 
I - fiist measurement 
II » second measurement 
* • flow not recorded due to malfunction of Spirometer 
The mean of the tracheobronchial retention curves of the first and the second test of 
all subjects is presented in Figure 1. Statistical analysis of these two curves revealed 
no significant difference. 
Two-way ANOVA of the percentages activity cleared and the areas under the 
retention curve revealed no systematic difference between the first and second test 
(p-value > 0.25). The clearance of radioactivity expressed as percentage of the initial 
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amount of radio-activity cleared 2 
(2h), 4 (4h), and б hours after in­
halation (6h) in the first (I) and the 
second test (Π), was calculated and 
is listed in Table 2, including the 
intersubject COV for 2,4 and 6 h % 
clearance. The mean of the inter-
subject COV of the first and the 
second test of 2 h% clearance was 
44%. The intrasubject COV of this 
parameter was 15%. For 4 h % 
clearance these figures were 21% 
and 11% respectively, and for 6 h% 
clearance 12% and 5% respectively. 
The percentages of initial activi­
ty present 24 hours after inhalation 
of each test are listed in Table 1. 
Flow and 24-hour retention were 
negatively correlated (r = -0.70; 
ρ < 0.001) (see also Figure 2). 
Tracrwobronchtal rétention 
Ptrcenmgror mitili activity 
100 η 
240 300 360 
Time after mhalation(mifi) 
Figure 1. Tbe mean of tbe tracheobronchial retention 
curves of the first and the second test. 
Table 2. Clearance of radioactivity expressed as percentage of the initial amount of 
radioactivity cleared at 2 (2h), 4 (4h), and 6 hours after inhalation (6 h) in 
the first (I) and the second test (Π). 
Subject 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Mean 
SD 
COV* 
2 
I 
48 
53 
41 
39 
62 
67 
90 
15 
29 
44 
49 
21 
43 
h,% 
Π 
45 
45 
37 
49 
62 
47 
90 
30 
14 
42 
45 
20 
44 
4 
I 
60 
72 
82 
67 
78 
75 
95 
37 
55 
62 
68 
16 
24 
h,% 
Π 
85 
75 
73 
63 
80 
80 
95 
57 
58 
58 
72 
13 
18 
6h,% 
I 
83 
85 
85 
80 
83 
88 
95 
62 
73 
69 
80 
10 
12 
Π 
90 
85 
80 
74 
90 
90 
92 
60 
»1 
76 
82 
10 
12 
*COV » intersubject coefficient of variation. 
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Figure 3 shows the results of the 
calculated area under the retention 
curve up to 2 (AUC-2), 4 (AUC-4) 
and 6 hours after inhalation (AUC-
6) in the first and the second test. 
The intrasubject COV of the 
AUC-2, the AUC-4 and the AUC-6 
were 9%, 9% and 11% respectively. 
The mean of the intersubject COV 
of the AUC-2 was 20%. For the 
AUC-4 and AUC-6 this was 28% 
and 31% respectively. 
In table 3 are presented the 
numbers of subjects required to be 
entered into a cross-over study in 
order to detect given differences in 
the 2, 4 and 6 h% clearance or 
AUC-2, 4 and 6, with various 
probabilities of success at ρ < 0.05. 
flow of inhalations 
(l/min) 
100 
BO 
detest 
^ t e s t 
60-
40-
20 
L·, 30 A0 
— ι — 
70 50 60 
24-hour retention (%) 
Figure 2. Relation between the average flow of the 
inhalation and the 24-hour retention. 
Table 3. Number of subjects needed to be entered in a cross-over study in order to 
detect given absolute differences in 2,4 and 6 h% clearance or area under 
the tracheobronchial retention curve up to 2 (AUC-2), 4 (AUC-4) and 6 
hours after inhalation (AUC-6) at ρ < 0.05 with various probabilities of 
succes (power). 
clearance 
(%) 
2 h 5 
10 
15 
20 
4 h 5 
10 
15 
20 
6 h 5 
10 
15 
20 
70 
26 
7 
3 
2 
28 
7 
3 
2 
9 
2 
1 
1 
75 
30 
8 
3 
2 
31 
8 
4 
2 
10 
3 
1 
1 
Power 
80 
33 
8 
4 
2 
35 
9 
4 
2 
11 
3 
1 
1 
(%) 
70 
6 
2 
1 
1 
16 
5 
3 
1 
30 
10 
5 
3 
75 
7 
2 
1 
1 
18 
6 
3 
2 
35 
11 
6 
3 
80 
8 
2 
1 
1 
20 
7 
3 
2 
39 
13 
6 
3 
AUG 
(% hrs) 
20 
35 
50 
70 
20 
35 
50 
70 
20 
35 
50 
70 
AUC-2 
AUC-4 
AUC-6 
30 
Discussion 
This study was performed to 
evaluate inter- and intrasubject 
variability of the tracheobron­
chial clearance as measured 
using the technique described by 
Thomson and Short4. 
The clearance rate is influ­
enced by the deposition pat­
tern14. The deposition itself de­
pends on particle size, mode of 
inhalation and airway patency. 
The spinning top generator pro­
duces a monodisperse aerosol. 
The volume and the flow of the 
inhalations in each subject were 
similar in the first and second 
test (see Table 1). In healthy 
non-smokers airway patency 
should not be a factor. The re­
sulting 24-hour retention was not 
significantly different in the two 
tests. It is assumed that 24-hour 
retention is equivalent to alveolar 
deposition15, or rather: deposition 
in the non-ciliated regions of the 
lungs. The negative correlation 
between flow of inhalation and 
24-hour deposition is therefore 
as to be expected. Even at this flow, and while rebreathing of particles was prevented 
by means of a one-way valve system, there was a significant deposition of 5 μπι 
particles in the most distal regions of the lung in these healthy subjects. The mean 
24-hour retention in our study was 52%. Using the same technique Agnew et al 
found a mean 24-hour retention of 41% at a mean inspiratory flow of 49 1/min in 9 
non-smoking volunteers14. The mechanical properties of the lung are known to 
change with age, but the relation between age and aerosol deposition is not certain. 
Because data on the age of the subjects in the study of Agnew et al are not available, 
it remains questionable whether the results of their study can be compared with our 
results. 
Using a 5 /im polystyrene aerosol also, Thomson and Short found in 3 non­
smoking healthy volunteers with a mean age of 56 years a mean 24-hour retention of 
42%4. The volume of the inhalations was 110 ml. The flow of the inhalations is not 
mentioned. 
Camner and Philipson reported a mean alveolar deposition of 52% in 10 healthy 
volunteers measured on two occasions16. The test aerosol contained 4 /im teflon 
Area under the retertoon сип« 
IV.hrs) 
0-2h all« iBhaèïlion 
МШйШ 
200-
100-
0 -6 h after inhalation 
300 
WO È 
subject 1 2 3 4 5 6 7 
D f irsi lest •second lest 
Figure 3. The area under the retention curve up to 2 
(AUC-2), 4 (AUC-4), and 6 hours after inhalation (AUC-
6) in the first and the second test of all subjects. 
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particles tagged with "'In. These subjects performed 20-30 maximum inhalations at 
a 30 1/min rate. Their mean age was 27 years. 
Booker et al used a S μ m 51Cr (half-life 28 days) labelled polystyrene aerosol in 
3 subjects15. After a single 500 ml inhalation at normal breathing level followed by a 
10 second breath-holding pause, they found an alveolar deposition of 75,65 and 75%. 
Stahlhofen et al found in 5 healthy non-smoking subjects a mean 24-hour retention 
of 74%". The age of these subjects ranged from 40 to 50 years. The radio-aerosol 
contained teflon particles with an aerodynamic diameter of 4.7 micrometer. The 
aerosol was inhaled at a flow rate of 15 1/min and an inspiration time of 4 seconds. 
In another study by Stahlhofen et al, dealing with particle deposition in relation 
to particle diameter and flow of inhalation, alveolar deposition of 5 μ m particles 
appeared to be 65% at a 45 l/min and 79% at a 151/min flow rate18. Deposition was 
measured several times in 3 healthy non-smoking subjects while the particle diameter 
was varied. The aerodynamic particle diameter ranged from 1 to 10 micrometer. The 
test aerosol contained iron oxide particles tagged with 198Au. 
Finally our results are in agreement with the model for aerosol deposition of the 
Task group on Lung Dynamics, which assumes tracheobronchial and alveolar 
deposition of 5 μ m particles to be equal19. The discrepancies between the reported 
deposition patterns may have been due to type, number, positioning and collimation 
of the detectors used. Apart from the study by Agnew et al14 the set-up to measure 
intrathoracic activity in our study was different from every other study mentioned 
above. It is obvious, however, that the results of measuring the 24-hour retention in 
our study appear to be not so astonishing in view of the literature. 
There are several methods to quantitate the results of tracheobronchial clearance 
measurements20. The AUC-6 comprises the results of the measurements of the whole 
period during which most of the clearance is completed. This parameter is therefore 
likely to be the most sensitive with respect to detecting overall effects of different 
interventions. 
In table 4 coefficients of variation for various measurements of tracheobronchial 
clearance reported in other studies and this study are listed. Our results compare 
favourably with those reported in other studies. 
In table 3 the results are listed of the calculation of the number of subjects 
needed to be entered in a cross-over study in order to detect given absolute differ­
ences with various probabilities of success. It seems obvious that as the absolute 
differences to be detected are smaller the number of subjects needed does increase. 
Also a higher probability of success requires a larger number of subjects. We 
deliberately have chosen several absolute differences and powers identical to those 
listed in the study of Del Donno et al.11 to be able to compare their results with 
those of our study. The numbers of healthy non-smoking subjects needed to be 
entered in cross-over studies as based on the results of our study are far lower than 
the numbers of chronic bronchitic or asthmatic patients mentioned in their study11. 
The rather small number of subjects required for detecting differences in 6 h% 
clearance seems to be remarkable. It must be explained by the fact that in healthy 
subjects tracheobronchial clearance is practically completed in 6 hours resulting in 
little variation in 6 h% clearance values. Looking at the numbers of subjects needed 
to detect differences in area under the retention curve it must be noted that, as 
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Table 4. Coefficients of variation for various measurements of tracheobronchial 
clearance. Comparison of our results with those reported by other studies 
including healthy non-smokers. 
PucheUe et al. (8) 
Yeates et al. (10) 
Our study 
Wilkey et al. (9) 
Our study 
Wilkey et al. (9) 
Our study 
Our study 
Our study 
Our study 
Camner et al. (7) 
Number of 
subjects 
16 
22 
10 
9 
10 
9 
10 
10 
10 
10 
8 
Type of 
measurements 
lh%TBC 
2h%TBC 
2h %'VBC 
2h%TBR 
4h %TBC 
4h%TBR 
6h %TBC 
AUC-2 
AUC-4 
AUC-6 
biological Іц 
Intrasubject Intersubject 
COV (%) 
16 
20 
15 
14 
11 
29 
5 
9 
9 
11 
25 
COV (%) 
42 
43 
44 
35* 
21 
45* 
12 
20 
28 
31 
76* 
2h, 4h, 6h %TBG % of tracheobroncbial deposition cleared at 2, 4 and 6 hours after radio-aerosol 
inhalation; 2h, 4h %TBR: % of tracheobronchial deposition present at 2 and 4 hours after radio-aerosol 
inhalation; biological t^: biological half-lives extrapolated from the clearance curves. AUC-2, 4 and 6: 
area under tracheobronchial retention curve up to 2, 4 and б hours after radio-aerosol inhalation. 
* derived from published data. 
mentioned above, the AUC comprises all measurements during a whole period. 
Therefore the longer the period the larger the differences inevitably will be. A 
certain absolute difference in, for instance, AUC-2 is therefore comparable only with 
a larger absolute difference in, for instance, AUC-6. 
It is obvious that in order to determine the number of subjects needed to be 
entered in a cross-over trial, it has to be decided first which difference is considered 
as being clinically relevant. 
On the basis of the results of this study it can be concluded, that tracheobronchial 
clearance in healthy non-smoking subjects has considerable intersubject variability but 
also there is far less intrasubject variability, which is in agreement with other 
studies7"11. 
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Chapter Ш 
Conventional physiotherapy and forced 
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similar effects on tracheobronchial clearance 
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ABSTRACT 
This study compared the effect of two forms of chest physiotherapy. In the 'conven­
tional' form of physiotherapy, postural drainage was combined with percussion and 
directed coughing. The other, relatively new form of physiotherapy, was the forced 
expiration technique, i.e. huffing combined with postural drainage, breathing exercises 
and, if necessary, coughing. Eight patients (six with cystic fibrosis, two with agamma-
globulinaemia) took part in the study. No difference was found in tracheobronchial 
clearance, regional lung clearance, sputum production or lung function between the 
two forms of treatment. The forced expiration technique can be performed without 
an assistant. Therefore, it is concluded that in general the forced expiration technique 
is preferable. 
M. van Hengstum, afdeling Longziekten, University Hospital Nijmegen, Geert Groote­
plein Zuid 8, p.o. box 9101, 6500 HB Nijmegen, The Netherlands. 
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Several techniques of chest physiotherapy have been developed in order to improve 
mucus mobilization in patients with retention of bronchial secretions. 
Two frequently used regimens are conventional physiotherapy (CONY) and the 
relatively new forced expiration technique in combination with postural drainage 
(FET). CONV usually implies the combination of percussion and/or vibration with 
postural drainage and directed coughing. FET consists of huffing and breathing 
exercises combined with postural drainage and can be performed without an assistant. 
By means of various non-invasive techniques using radionuclides, the effect of 
components of these regimens on mucus clearance have been evaluated separately 
and in combination with each other1'8. In contrast with the study by Oldenburg et al.1, 
other studies have shown that postural drainage enhances tracheobronchial clear-
ance2^. Percussion and vibration have appeared to be relatively ineffective5^ and do 
not seem to add to the effectiveness of the combination of coughing, breathing 
exercises and postural drainage7. FET, even without postural drainage, enhances 
tracheobronchial clearance8. 
To our knowledge, no study has compared the effectiveness of conventional 
physiotherapy with that of the FET, both including postural drainage, using the 
objective in vivo assessment of tracheobonchial clearance by means of a radio-aerosol 
technique. The aim of this study was to compare the effect on tracheobronchial 
clearance and regional lung clearance of conventional physiotherapy with that of the 
forced expiration technique. 
Methods 
Patients 
Six patients with cystic fibrosis and two with agammaglobulinaemia took part in the 
study. Their mean age was 23 yrs (range 15-27 yrs). The mean forced expiratory 
volume in one second (FEV,) was 65 (SD ±29)% predicted. The mean vital capacity 
(VC) was 80 (SD±19)% predicted. The mean sputum production was 53 g per day. 
Stndy design 
In order to standardize the treatment as much as possible only two experienced 
physiotherapists participated. The duration of a CONV- or FET-session was 30 min. 
Both regimens included postural drainage consisting of six positions, four lying on 
a tilted bed (15° head down) and two seated (leaning 45° forward and 30° backwards, 
respectively). During CONV, in each position, percussion was applied for 4 min 
followed by a few deep breaths and directed coughing. FET was applied according 
to standard procedures9. During FET, in every postural drainage position, the 
patients were instructed to start with diaphragmatic breathing. When the patient had 
relaxed sufficiently this was followed by thoracic expansion exercises and again 
diaphragmatic breathing. Then followed two huffs (maximal forced expirations from 
mid-lung volume) with chest compression alternated with relaxed diaphragmatic 
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breathing. If necessary the patients coughed. FET was performed without aid. The 
protocols of CONV and FET were similar to the regimens in clinical practice. There 
was a four-day treatment period in a randomized order for both CONV and FET. 
The Brst three days were used for daily instruction and treatment of the patients. On 
the fourth day the effect of the respective treatments was assessed. Medication was 
continued unaltered during the study. The clinical condition of the patients had to be 
stable for at least six weeks prior to and during the study period. 
The patients were informed about the design and the aims of the study. Written 
informed consent was obtained. The study was approved by the Medical Ethics 
Committee of the hospital. 
Test parameters 
Tracheobronchial clearance was measured using a radio-aerosol technique10. A 
monodispersed 5 μ m "Tc-labelled polystyrene particle aerosol was inhaled under 
standardized conditions. 
The radioactivity in the thorax was measured by means of two horizontally 
opposed scintillation detectors. One detector was placed in front of the seated subject 
and centred at the sternum, and the other behind the subject and centred at the 
spinal column. Measurements were started directly after inhalation and repeated at 
regular intervals, i.e. approximately every 20 min up to 2,5h after physiotherapy was 
started and once more at 24h after inhalation. As described by Pavia et α/.11, the sum 
of the radioactivity count rates of the two detectors was corrected for background 
activity, isotope decay and 24h retention. The latter is considered to be an estimate 
of the aerosol deposition in the non-ciliated regions of the lung. The corrected count 
rate was expressed as a percentage of the count rate assessed immediately before the 
start of the physiotherapy. These percentages were plotted against time after the start 
of the physiotherapy, thus resulting in tracheobronchial clearance curves. The mean 
of the eight individual clearance curves obtained during either CONV or FET was 
calculated using the values actually measured at 20 min intervals. In the case of dif­
ferent intervals interpolations were made. 
Regional lung clearance was estimated by means of gamma-camera imaging as 
described by Agnew et al.11 with the exception of correction for alveolar depostion. 
A posterior 40,000-count image was recorded directly before and after each 
therapy session. Each subject also had a 200,000-count posterior ventilation study 
using radioactive krypton (81mKr). The gamma-camera images were recorded in 64x64 
format with a MDS computer system (MDS-A2, Medtronic Medical Data Systems, 
Ann Arbor, Michigan, USA). 
By means of the contours of the eimKr image a 5x8 matrix was fitted on each lung. 
The lungs were thereby divided into inner, intermediate and peripheral zones (fig. 1). 
Regional clearance after physiotherapy was expressed as a percentage of the count 
rate in a particular zone before the treatment plus the commulative loss of count rate 
from more peripheral zone(s). 
Sputum was collected during the physiotherapy session and during the 24h 
following the radio-aerosol inhalation. Sputum wet weight was recorded. In addition 
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sputum was dried for 72h at 
50oC to determine sputum dry 
weight. 
Flow volume curves were 
measured just before radio-aero­
sol inhalation and at about 90 
min after physiotherapy. 
The Wilcoxon test for paired 
data was used to evaluate the 
significance of any differences 
observed. 
Results 
No significant difference between 
24h retention after CONV and 
after FET was found. The mean 
24h retention was 42 (SD ±12)% 
and 38 (SD ±15)%, respectively. 
The mean curves of the 
tracheobronchial clearance ob­
tained during CONV and FET are presented in figure 2. At every interval there 
appeared to be no significant difference between the two curves. The results of the 
measurement of regional lung clearance are shown in figure 3. Again no significant 
differences were found between CONV 
and FET. 
The mean sputum production 
during the treatment was 754 mg 
(SD ±733) dry weight for FET. The 
mean 24h sputum production was 51 g 
(SD ±52) wet weight for CONV and 55 
g (SD ±58) wet weight for FET. 
The mean values for FEV, and 
forced vital capacity (FVC) before and 
after CONV and FET, respectively, are 
listed in table 1. There was no change 
in lung function after physiotherapy nor 
were there significant differences be­
tween CONV and FET. 
Fig. 1. - 5x8 matrix fitted to the 15 and 30% contours of 
the 81шКг ventilation image. A: inner zone; B: intermediate 
zone; С peripheral zone. 
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Fig. 2. - Mean tracheobronchial clearance curves. 
Table 1. - Lung function data (η=8). 
Mean FEVi / 
Mean FVC / 
before 
CONV 
2.3 
3.5 
after 
2.4 
3.7 
before 
2.3 
3.7 
FET 
aft( 
25 
There appeared to be no correlation between the amount of 24h sputum production 
and the effect of either treatment on tracheobronchial clearance or regional lung 
clearance, nor between the degree of airway obstruction and clearance. 
Discussion 
Bateman et al.13 described the effectiveness of the combination of percussion, 
vibration and postural drainage compared to control. Sutton et al.s demonstrated the 
effect of FET alone and combined with postural drainage compared to control9. The 
radio-aerosol technique, which has been used to measure tracheobronchial clearance 
in both these studies, is identical to the technique used m our study. Since the 
efficacy of both CONV and FET had been proven in the two studies mentioned 
above, no control measurement was 
included in our study. 
The design of the study and the 
protocols of the two treatments were 
such, that the common practice of the 
patients requiring daily chest physio­
therapy was mimicked as closely as 
possible. The results of this study are 
therefore, directly applicable to the 
treatment of these patients. However, 
the design of the study, i.e. three days 
with optimal chest physiotherapy 
whilst effects were evaluated on the 
fourth day, may have had a negative 
effect on the discriminative power of 
the study. 
In our study no significant differ­
ence was found between the two treat- Rg- 3. - Mean clearance from the peripheral, inter­
ments, which both included postural m e d i a t c a n d i n n e r ^ a f t e r ^ aná CONV· 
drainage. Therefore, the question 
arises whether the addition of other techniques (percussion, FET) substantially 
increases the effect of postural drainage. In several studies5'7 no additional effect of 
percussion has been shown. Furthermore, chest physiotherapy consisting of postural 
drainage in several postions during one session, including percussion, has been shown 
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to produce a fall in oxygen saturation14. A more recent study15 showed a fall in 
oxygen saturation particularly related to chest percussion. The forced expiration 
technique appeared to increase the efficacy of postural drainage8. After proper 
instruction and training practically every patient can perform the forced expiration 
technique without assistance. Patients, who require regular physiotherapy, therefore 
become more independent. It is important to prevent physiotherapist dependency in 
these patients. Independence also reduces expense related to treatment by a physio-
therapist. Despite this and the fact that the value of percussion and vibration still 
remains to be proven, many doctors and physiotherapists, as well as patients, seem 
to be reluctant to switch from conventional physiotherapy to the forced expiration 
technique. 
On the basis of the results of this study it can be concluded that the forced 
expiration technique, including postural drainage, is as effective as conventional 
physiotherapy. In view of the considerations mentioned above the forced expiration 
technique is preferable, especially for long-term treatment. 
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RÉSUMÉ: Cette étude compare les effets de deux formes de physiothérapie thoracique. Dans la forme 
'conventionnelle', on a combiné le drainage postural avec la percussion et la toux dirigée. L'autre forme, 
relativement nouvelle, de physiothérapie, consiste en une technique d'expiration forcée, avec halèment, 
drainage postural, exercises repiratoires, et toux en cas de nécessité. S patients ont participé à l'étude 
(6 cas de fibrose kystique, 2 cas d'agammaglobulinemie). On n'a pas trouvé de différence entre les deux 
techniques en ce qui concerne la clearance trachéo-bronchique, la clearance pulmonaire régionale, la 
production d'expectorations, ou les épreuves fonctionnelles pulmonaires. La technique d'expiration 
forcée peut ¿tre réalisée sans assistance. Cest la raison pour laquelle on conclut qu'en général il y a 
lieu de préférer cette dernière technique. 
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ABSTRACT 
In a randomized cross-over trial, including a control measurement the effect of 
positive expiratory pressure (PEP) and forced expiration technique (FET) on 
tracheobronchial clearance was evaluated in eight chronic bronchitics with abundant 
sputum production (mean, 32 g/day). PEP consisted of PEP-mask breathing inter­
spersed with breathing exercises, huffing, and coughing. FET consisted of postural 
drainage, breathing exercises, huffing, and coughing. Clearance was measured with 
a radio-aerosol technique. At 40 min after the start of therapy the mean clearance, 
expressed as percentage of the amount of radioactivity present at the start of therapy, 
was 32% after PEP, 53% after FET, and 15% in the control run. The difference 
between PEP, FET, and control was statistically significant (p<0.02). Sputum 
production during PEP and FET was larger than during the equivalent period of 
time in the control run. It is concluded that FET is more effective than PEP in 
enhancing tracheobronchial clearance. 
M. van Hengstum, M.D., Afdeling Longaekten, University Hospital Nijmegen, Geert 
Grooteplein Zuid 8, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. 
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Positive expiratory pressure (PEP) breathing is thought to mobilize secretions in 
occluded airways by increasing collateral ventilation1. Recently, the beneficial effect 
of positive airway pressure by mask has been reported in the treatment of surgical 
patients with atelectasis2. Since then, there have been several other studies on the 
clinical effects of PEP. Enhancement in sputum production314 and improvement in 
lung function variables3,5'6 have been described. In a recent study PEP was found to 
have no effect on clinical variables7. The lack of consistency in the results of these 
studies could be due to the choice of factors. The measurement of tracheobronchial 
clearance with a non-invasive radio-aerosol technique is an objective in-vivo assess­
ment of the effect of chest physiotherapy8. By this technique the efficacy of the forced 
expiration technique (FET), especially when combined with postural drainage, has 
been demonstrated9. No study dealing with PEP has used the measurement of 
tracheobronchial clearance. 
The aim of this study was to assess the effect of PEP-mask physiotherapy on 
tracheobronchial clearance as compared with the forced expiration technique in 
patients with chronic bronchitis. Furthermore, lung function and sputum production 
were measured. 
Patients and methods 
Eight patients (seven male, one female) with chronic bronchitis as defined in 
accordance with the MR С criteria10 took part in the study. 
The mean age of the patients was 63 (range, 48-73) years. The mean forced 
expiratory volume (FEV,) was 1.79 1 (SD ±0.65 1); the mean forced vital capacity 
(FVC), 3.07 1 (SD ±1.07 1); and the mean FEW JVC was 49 (SD ±15)% - that is, 
64% of predicted. The mean sputum production was 32 (range, 16-58) g/day. 
If medication was taken, this was continued unchanged during the study. 
In each patient tracheobronchial clearance was measured three times (PEP, 
FET, and control) on separate days with at least 2 days in between. The sequence 
of the measurements in each patient was determined at random. Several days 
before each measurement the patients were made familiar with the use of the 
PEP-mask and the forced expiration technique during at least three separate 
sessions. On the 2 days directly before each measurement no physiotherapy at all 
was allowed. 
The protocol of a PEP session included PEP-mask (Astra-Meditec, the Nether­
lands) breathing for 2 min at a PEP level of 10-15 cm H 2 0, sitting with the elbows 
resting on a table, followed by a few cycles of abdominal breathing, after which the 
patient performed a few huffs (forced expirations from mid-lung volume). Mobilized 
secretions reaching the central airways were cleared by coughing. This procedure was 
performed five times, resulting in a total duration of about 20 min. The FET-session 
protocol included six positions of postural drainage, of which four were in the 
Trendelenburg position. In each position the patient started with relaxed abdominal 
breathing, followed by thoracic expansion exercises. After that the patient resumed 
relaxed abdominal breathing interspersed each time with a few huffs (maximum 3). 
SeCTetions in the central airways, if present, were expectorated. The duration of a 
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FET session was about 30 min. During the control measurement the patient had no 
physiotherapy and coughed only spontaneously. 
The variables in this study included tracheobronchial clearance, lung function, 
and sputum production. 
Tracheobronchial clearance was measured with a radio-aerosol technique11. A 
monodisperse 5-μ m "Tc-labelled polystyrene particle aerosol was inhaled from a 
90-1 air-tight tank. This tank was linked in series with a wet spirometer (Pulmotest, 
Godart) by which the now of the inhalations was registered and their volume con­
trolled, aiming at 400-500 ml. For each test this volume was inhaled 15 times. Physio­
therapy was not started until 40 min after inhalation of the tracer, to avoid the most 
rapid clearance phase. The radioactivity in the thorax was measured by means of two 
horizontally opposed scintillation detectors (5-cm thallium-activated Nal crystals). 
One detector was placed in front of the seated patient and centred midway on the 
sternum, and the other was placed behind the patient and centred at the spinal 
column. Radioactivity was measured during 90 sec at regular intervals up to 2.5h 
after the physiotherapy was started and once more 24h after inhalation, because the 
latter is supposed to be an estimate of radio-aerosol deposition in the non-ciliated 
regions of the lungs. In four patients one more measurement was performed about 
7h after inhalation. The sum of radioactivity count rates of the two detectors was 
corrected for background activity, isotope decay, and 24-h retention. 
These corrected count rates were expressed as a percentage of the count rate 
assessed immediately before the start of physiotherapy. These data were plotted 
against time after the start of physiotherapy, resulting in tracheobronchial clearance 
curves. The mean of the eight individual clearance curves obtained during either 
PEP, FET, or control was calculated by using the interpolated percentages at 20-min 
intervals. The area under the clearance curve of each individual measurement was 
calculated by using non-fitted data and expresed in arbitrary units (hours). 
Lung function was measured just before inhalation of the radio-aerosol and about 
1.5h after physiotherapy, including a flow volume curve and sGaw by means of a 
body Plethysmograph (Jaeger Bodyscreen Π). 
Sputum production during PEP, FET, and control periods and during the 
remainder of the day of measurement was recorded by weighing the sputum samples. 
The macromolecular content of the sputum samples was determined by weighing 
them after drying for 3 days at 50oC. 
Wilcoxon's test for paired data was used to evaluate the significance of any differ­
ences observed. 
Written informed consent was obtained from each patient. The study was 
approved by the Medical Ethics Committee of the hospital. 
Results 
The data on the 24-h retention of radioactivity are presented in Table 1. No signifi­
cant differences were found. 
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Table 1. - Data on tracheobronchial retention (mean ± SD, /1=8). 
PEP FET Control 
24-h retention (% initial deposition) 
Retention after therapy Φ 
AUC 150§ (h) 
34 : 
70 : 
167 
16 
14' 
26' 
31 ± 10 
4 6 + 1 5 1 · 
120 ± 281" 
36 ± 18 
86 ± 16 
1 9 2 + 3 9 
• ^<0.05 as compared with control; -J- ρ < 0.02 as compared with PEP and control; t Percentage of 
radioactivity present at start of physiotherapy, § AUC 130 ·= aria under the clearance curve 0-150 min 
after the start of physiotherapy. 
The mean curves of 
the tracheobronchial 
clearance obtained 
during and after 
PEP, FET, and con­
trol are presented in 
Fig. 1. At 20 and 40 
min there is a signifi­
cant difference be­
tween control and 
PEP (p<0.02). The 
FET curve was sig­
nificantly different 
from the control 
curve at each 20-min 
interval (p<0.02) but 
not at the 20-min 
value. 
The data on 
tracheobronchial 
retention after phys­
iotherapy are shown 
in Table 1. 
Table 1 also pre­
sents data on the 
mean area under the 
clearance curve up to 
ISO min after the 
start of physiotherapy 
(AUC 150). Tracheo­
bronchial retention at 
7h after inhalation of 
the radio-aerosol was 
measured in four 
patients. The mean 
percentages were 20 
Tracheo bronchial retention 
(% act. at start physioth ) 
100 
80 -
60 -
Д0 -
20 -
1 2 
Time after start of physioth 
Fig. 1. - The mean of the tracheobronchial clearance curves for PEP, 
FET, and control. 
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± 7%, 13 ± 8%, and 24 ± 24% for PEP, FET, and control, respectively. These 
results showed no significant differences. 
Lung function variables as measured before and after either of the treatments and 
control period were not significantly different (Table 2). 
Both for PEP and FET significantly more sputum was produced during physio­
therapy than during the equivalent period of time in the control measurement 
(p<0.02) (Table 3). 
During FET more sputum was produced than during PEP (p<0.0S). Sputum 
production during the 2h after therapy was the same for FET and PEP. The mean 
daily sputum production for FET, PEP, and control was not significantly different. 
Table 2. - Lung function data before and after therapy (n=8). 
Mean FEV! 
SD 
MeanFVC 
SD 
Mean sGawf 
SD 
Mean РЕРилз* 
SD 
PEP 
Before 
1.9 
0.7 
3.2 
1.0 
0.67 
0.25 
1.17 
0.48 
» 
After 
1.8 
0.6 
3.3 
1.0 
0.64 
0.24 
1.00 
0.42 
FET 
Before 
1.7 
0.6 
3.0 
1.0 
0.63 
0.21 
1.11 
0.45 
After 
1.7 
0.5 
3.0 
0.9 
0.69 
0.27 
1.04 
036 
Control 
Before 
1.8 
0.6 
3.0 
0.9 
0.66 
0.26 
1.13 
0.45 
After 
1.71 
0 5 1 
3.11 
0.91 
0.61· 
0.28* 
0.981sec 
0.421/sec 
* 1/sec-kPa. 
t sGaw = specific airway conductance. 
FEF^-Tjt = mean forcea expiiatoiy flow during the middele half of the FVC 
Table 3. - Data on sputum production (mean ± SD, л=8). 
During physiotherapy 
After physiotherapy 
(2h) 
24-h production 
PEP 
59 ± 57* 
55 ± 104 
29 ± 10 
FET 
249 ± 359 τ 
55 ± 55 
37 ± 13 
Control 
18 ± 32 mg 
dry weight 
83 ± 131 mg 
dry weight 
31 ± l l g 
wet weight 
* p<Q.02 as compared with control. 
Τ ρ <0.05 as compared with PEP and ρ < 0.02 as compared with control. 
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Discussion 
The aim of the study was to compare the effect on tracheobronchial clearance of 
PEP-mask physiotherapy with that of the forced expiration technique in patients with 
chronic bronchitis and abundant sputum production. 
The resulta of this study as expressed by the area under the clearance curve 
(AUC 150) indicate that both PEP and FET have a positive effect on tracheobron-
chial clearance compared with control. Analysis of the clearance curves shows that 
the effect of PEP is restricted to the period during and immediately after the 
treatment. After FET clearance is significantly more effective compared with both 
PEP and control even up to 2.5h after start of physiotheray. 
It has been suggested that PEP particularly enhances the clearance of secretion 
in small airways4. Therefore one should expect the effect to manifest itself not 
directly after the treatment but after some hours. To detect these effects additional 
measurements were performed in four patients 7h after inhalation. Our data show no 
change in the differences between PEP, FET, and control already present at 2.5h 
after start of therapy. This provides no support for the idea that PEP has delayed 
effects. 
For each treatment modality lung function variables, both for large and small 
airways, before and 1.5h after each single session, did not change significantly. The 
postulated delayed effect of PEP could not be detected by using these lung function 
variables also. 
FET resulted in the largest sputum production during the treatment. The data on 
sputum production during the 2h after physiotherapy again show no evidence of a 
delayed effect of PEP. 
The design of the study allows no conclusions with regard to the effect of PEP-
mask breathing alone, because PEP included huffing and coughing, whereas in the 
control measurement patients coughed only spontaneously. 
Both PEP and FET as used in this study enhanced tracheobronchial clearance. 
But FET was more effective than PEP. One of the reasons could be that postural 
drainage was not included in PEP. The importance of postural drainage also in 
combination with PEP has been demonstrated in a recent study7. The recommenda-
tions of the manufacturer seem therefore to be inadequate. 
We conclude that the forced expiration technique including postural drainage is 
more effective than positive expiratory pressure physiotherapy in patients with 
chronic bronchitis and abundant sputum production. 
Acknowledgement 
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IV. 2 The effect of positive expiratoiy pressure mask physiotherapy 
(PEP) versus forced expiration technique (FET) 
on regional lung clearance in chronic bronchitics 
Running title: Effect of PEP on regional lung clearance 
Michel van Hengstum*, Jan Festen*, Cañen Beurskens**, Marijke Hankel**, Freek 
Beekman***, Frans Carstens*** 
*Dept. of Pulmonary Diseases, **Dept. Physiotherapy, ***Dept. Nuclear Medicine, 
University Hospital Nijmegen, Nijmegen, The Netherlands 
Submitted for publication. 
ABSTRACT 
On theoretical grounds it is assumed that positive expiratory pressure mask physio-
therapy (PEP) as a means of promoting mucus clearance is especially effective in the 
more distal airways. In a randomized cross-over trial including a control measure-
ment the effect of PEP and of the forced expiration technique (FET) which was 
combined with postural drainage (PD) on regional lung clearance was evaluated in 
seven patients with chronic bronchitis and abundant sputum production (mean 32 
g/day). PEP consisted of positive expiratory pressure mask breathing interspersed 
with breathing exercises, forced expiration manoeuvres (huffing) and if necessary 
coughing. FET consisted of breathing exercises, huffing and also if necessary 
coughing. FET was combined with PD. Following inhalation of a radio-aerosol 
regional lung clearance was estimated by means of gamma camera imaging. The 
results after PEP appeared to be not significantly different from control. The mean 
clearance in all three lung zones (peripheral, intermediate and inner) was largest 
after FET with PD as compared with PEP and control. Statistical significance 
(p < 0.02) was reached only for clearance in the inner region. It is concluded that 
PEP has no demonstrable effect on regional lung clearance in these patients. 
M. van Hengstum, afdeling Longziekten, University Hospital Nijmegen, Geert Groóte· 
plein Zuid 8, p.o. box 9101, 6500 HB Nijmegen, The Netherlands. 
50 
Introduction 
It has been reported by Falk et al.1 that positive expiratory pressure mask physio­
therapy (PEP), which is performed in a sitting position only, is better accepted than 
other forms of chest physical therapy, which do include postural drainage. Most 
patients find it easier, less time consuming and more convenient because they can use 
it whenever necessary. 
PEP is thought to achieve its effect on mucus mobilization by increasing collateral 
ventilation2, thereby opening up airways occluded by secretions and also by pre­
venting airway collapse during expiration in obstructive lung disease3. It is assumed 
therefore that the effect of PEP on the mobilization of secretions in the peripheral 
airways is more pronounced than for instance the effect of coughing and possibly 
also of the forced expiration technique (FET),. There exists no study in which the 
effect of positive expiratory pressure in vivo on clearance in separate regions of the 
lungs has been evaluated. 
The aim of this study was to assess by means of an objective radio-aerosol 
technique the effect of PEP on regional lung clearance in patients with chronic 
bronchitis, as compared with FET, which included postural drainage (PD). 
Methods 
Patients 
Seven patients (6 males, 1 female) with chronic bronchitis according to the MRC 
^епа'* took part in the study. Their mean age was 62 (range 48-73) years. The 
mean FEV, was 56 (SD ±21) % predicted, the mean FVC 75 (SD ±29) % predicted, 
and the mean FEV1/VC% 64 (SD ±22)% predicted. The mean sputum production 
was 32 (range 16-58) grams/day. 
Study design 
In order to standardize the treatment as much as possible only two experienced 
physiotherapists participated in the study. PEP included positive expiratory pressure 
mask (Astra-Meditec, The Netherlands) breathing for two minutes at a level of 10-
15 cm H20 sitting with the elbows resting on a table, followed by a few cycles of 
abdominal breathing after which the patient performed a few huffs (maximal forced 
expirations from mid-lung volume). Mobilized secretions reaching the central airways 
were cleared by coughing. This procedure was performed five times resulting in a 
total duration of about twenty minutes. 
FET was applied according to standard procedures5 and was combined with PD. 
This consisted of six positions of which four lying on a tilted bed (15° head down) 
and two in the sitting position (leaning 45° forward and 30° backward respectively). 
In every position the patient was instructed to start with diaphragmatic breathing. 
When the patients had relaxed sufficiently this was followed by thoradc expansion 
exercises and again diaphragmatic breathing. Then followed 2 huffs with chest 
compression alternated with relaxed diaphragmatic breathing. If necessary, the 
patient did cough. The duration of a FET-session was about 30 minutes. 
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Both PEP and FET with PD were performed without aid. During the control 
measurement the patient had no physiotherapy and coughed only spontaneously. In 
each patient the three measurements (PEP, FET with PD and control) were per­
formed in a randomized order on separate days with at least two days in between. 
Medication was continued unaltered during the study. The clinical condition of 
the patient had to be stable for at least six weeks prior to and during the study period. 
The patients were informed about the design and the aims of the study. Written 
informed consent was obtained. The study was approved by the Medical Ethics 
Committee of the hospital. 
Test parameters 
The effect of either treatment was assessed by measuring the clearance of an inhaled 
radio-aerosol. The aerosol consisted of monodisperse 5 μια " T c labelled polys­
tyrene particles6 and was inhaled under standardized conditions. 
Regional lung clearance was calculated by means of gamma camera imaging as 
described by Agnew et al.7 with the exception of the correction for alveolar deposi­
tion. A posterior 40,000 count image was recorded directly before and after each 
therapy session. Each subject also had a 200,000 count posterior ventilation study 
using radioactive krypton (8'mKr). The gamma camera images were recorded in 64x64 
format with a MDS computer system (MDS-A2, Medtronic Medical Data Systems, 
Ann Arbor, Michigan, USA). By means of the contours of the ""Кг image a 5x8 
matrix was fitted on each lung. Thereby the lungs were divided into inner, inter­
mediate and peripheral zones (see figure 1). Regional clearance after physiotherapy, 
and in the control run after a similar time lapse, was expressed as percentage of the 
count rate in a particular zone 
before the treatment plus the 
cumulative loss of count rate 
from more peripheral zone(s)7. 
To estimate the deposition 
pattern of the radio-aerosol both 
24 h retention and penetration 
index were calculated. 24 h re­
tention of the radio-aerosol was 
determined as described by Pavia 
et al.*. For this the radio-activity 
in the thorax was measured by 
means of two horizontally op­
posed scintillation detectors, one 
was positioned in front and the 
other behind the seated patient. 
Measurements were made direct­
ly after and at 24 hours after 
inhalation of the radio-aerosol. „ . , „ . _ . . «, . „„„, 
ш и к а н и и υι int. ι aiuu а ы uaui. Rgure i. 5 χ g matrix fitted to the 15 and 30% contours of 
Furthermore, using the gamma the 81mKiypton ventilation image. A; inner zone; B: inter­
mediate zone; C: peripheral zone. 
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camera data, the penetration index (PI) of the radio-aerosol was calculated as 
described by Agnew et al.9. 
The Wilcoxon test for paired data was used to evaluate the significance of any 
differences observed. 
Results 
No significant difference was found between the values for 24 h retention in the three 
measurements. The mean values were 31 (SD ±20)% after PEP, 28 (SD ± 14)% after 
FET with PD and 34 (SD ±19)% in the control run. Neither was there a significant 
difference between the PI values. The mean values were 0.51 (SD ±0.24) for PEP, 
0.46 (SD ±0.23) for FET with PD and 0.55 (SD ± 0.23) in the control run. The 
results of the calculated regional lung clearance are shown in figure 2. The mean 
clearance in all three lung zones was 
largest after FET with PD as com­
pared with PEP and control. Statis­
tical significance (P ^ 0.02) was 
reached only for clearance in the 
inner region after FET with PD as 
compared with both PEP and control. 
Discussion 
The purpose of this cross-over study 
was to assess the effect of PEP-mask 
physiotherapy on regional lung clear­
ance particularly in the peripheral 
airways as compared with FET. 
There exists no such study until now. 
In this type of study comparison 
of the individual results is allowed 
only if there is little variation in 
aerosol deposition in each patient. 
Therefore a monodisperse aerosol 
was used. The inhalation procedure 
was standardized. The values of 24 h 
retention, which is considered an 
estimate of aerosol deposition in the non-ciliated regions in the lungs, did show no 
consistent differences between the three runs (PEP, FET with PD and control). Nor 
did the results of the calculated PI, which is another estimate of aerosol deposition. 
In the calculation of the regional lung clearance no correction has been made for 
alveolar deposition as described by Agnew et al.7. As a consequence thereof regional 
clearance is probably underestimated. This holds particularly true for the peripheral 
region because deposition in alveoli compared with deposition in conducting airways 
is largest in this region. This correction has not been made because gamma camera 
Clearance (%) 
Inner Intermed. Peripheral 
Lung zones 
* ρ ¿0.02 
Figure 2. Mean clearance from the peripheral, inter-
mediate and inner zone after PEP, FET with PD and 
control 
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images at 6 hours after inhalation of the radio-aerosol have not been recorded. These 
are necessary to calculate the estimate of alveolar deposition. To our experience the 
amount of radioactivity present in the lungs at 6 hours after inhalation is so little, 
that gamma camera images show rather poor statistics. Furthermore this was a cross­
over study, so there was no strong need for such a correction. As shown in figure 2, 
the mean clearance in every lung region (inner, intermediate and peripheral) is 
largest after FET with PD. Significance is reached only in the inner region. In every 
single patient clearance in the inner region was largest after FET with PD. After 
PEP there is no significant effect at all. These results are in agreement with those 
reported by Hofmeyr et al.10. The effect of PEP and FET with PD on tracheo­
bronchial clearance as we have reported earlier do support the findings in the 
present study11. Both PEP and FET with PD in this study included huffing inter­
spersed with diaphragmatic breathing. Because PEP is ineffective, as shown in this 
study, probably the most effective components of FET with PD are postural drainage 
and/or the thoracic expansion exercises. 
Postural drainage alone has been shown to be effective in mobilizing secre­
tions1243. The additional effect of expansion exercises remains to be elucidated. It is 
thought that these exercises improve ventilation in atelectatic parts of the lung (5). 
They are considered an essential part of the FET protocol. Further studies are to be 
done. In conclusion, the results of this study indicate that PEP has no effect on 
regional lung clearance. In contrast FET combmed with postural drainage appeared 
to have a significant effect on clearance in central airways. 
References 
1. Falk M, Kelstnip M, Andersen JB, et al. Improving the ketchup bottle method with positive 
expiratory pressure, PEP, in cystic fibrosis. Bur J Respir Dis 1984; 65:423-32. 
2. Andersen JB, Quist J, Капп T. Recruiting collapsed lung trough collateral channels with positive end 
expiratory pressure. Scand J Respir Dis 1979; 60:260-266. 
3. Groth S, Stafanger G, Dirksen H, et al. Positive expiratory pressure (PEP-mask) physiotherapy 
improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol 
Rapir 1985; 21:339-343. 
4. Medical Research Council. Definition and classification of chronic bronchitis for clinical and 
epidcrmiologjcal purposes. Lancet 1965; i:775-779. 
5. Gaskell DV, Webber BA, eds. The Brompton Hospital Guide for Chest Physiotherapy, 4th ed. 
Oxford: Blackwell, 1980. 
6. Thomson ML, Short MD. Mucociliary function in health, chronic obstructive airway disease and 
asbestosis. J Appi Physiol 1969; 26:535-539. 
7. Agnew JE, Batcman JRM, Pavia D, Clarke SW. A model for assessing bronchial mucus transport. 
J Nud Med 1984; 24:170-176. 
8. Pavia D, Batcman JRM, Clarke SW. Deposition and clearance of inhaled particles. Bull Eur 
Physiopathol Respir 1980; 16:335-366. 
9. Agnew JE, Pavia D, Clarke SW. Airways penetration of inhaled radio-aerosol; an index to small 
airways function? Eur J Respir Dis 1981; 62:239-255. 
10. Hofmeyr JL, Webber BA, Hodson ME. Evaluation of positive expiratory pressure as an adjunct to 
chest physiotherapy in the treatment of cystic fibrosis. Thorax 1986; 41:951-954. 
11. Van Hcngstum M, Pesten J, Beurskens C, et al. The effect of positive expiratory pressure versus 
forced expiration technique on tracheobronchial clearance in chronic bronchitics. Scand J Gastro­
enterol 1988; 23 (suppl. 143) 114-118. 
12. Sutton PP, Parker RA, Webber BA, et al. Assessment of the forced expiration technique, postural 
drainage and directed coughing in chest physiotherapy. Eur J Respir Dis 1983; 64:62-68. 
13. Sutton PP, Lopez-Vidriero MT, Pavia D, et al. Assessment of percussion, vibratory shaking and 
breathing exercises in chest physiotherapy. Eur J Respir Dis 1985; 66:147-152. 
54 
Chapter V 
No effect of oral high frequency oscillation 
combined with forced expiration manoeuvres on 
tracheobronchial clearance in chronic bronchitics 
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ABSTRACT 
This study compared the effect of oral high frequency oscillation (OHFO) with the 
effect of the forced expiration technique (FET) on tracheobronchial clearance. Eight 
patients with chronic bronchitis were investigated (mean age 60 ± 10 yrs, mean FEV, 
68 ±27% predicted, mean sputumproduction 33 ±9 g/day). OHFO was applied at 
the respiratory system resonant frequency of each patient (range 9.2-25 Hz) and 
combined with huffing. FET included breathing exercises, huffing and postural 
drainage. Duration of both OHFO and FET was 30 minutes. Tracheobronchial 
clearance was measured by means of a radio-aerosol thechique. At 60 minutes after 
start of the treatment mean tracheobronchial retention was 70 ±26% after OHFO, 
54 ±26% after FET and 76 ±18% in the control run, which included huffing only. 
OHFO was not significantly different from control. FET was significantly different 
(p < 0.02) from both OHFO and control. 
It is concluded that OHFO has no effect on tracheobronchial clearance in chronic 
bronchitics. 
M. van Hengstum, afdeling Longziekten, University Hospital Nijmegen, Geert Groote­
plein Zuid 8, p.o.box 9101, 6500 HB Nijmegen, The Netherlands. 
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Introduction 
In 1985 oral high frequency oscillation (OHFO) has been reported to increase 
mucociliary clearance in normal man.1 Since then it has been applied experimentally 
as a means of improving clearance of excessive bronchial secretion. Reports of its 
effectiveness in this respect show conflicting results varying from a significant 
increase in tracheobronchial clearance after OHFO combined with postural drainage 
and forced expiration2 to no direct beneficial effect on tracheobronchial clearance 
but only improvement in mucus transport through stimulation of the coughing 
reflex.3 The mechanism through which OHFO exerts its effect - if any - remains 
unclear. It has been suggested that OHFO changes the characteristics and/or 
production of mucus or does interact with ciliary beating. Whatever the mechanism 
might be it seems obvious that the effect of OHFO must be maximal when applied 
at respiratory system resonant frequency.1 It is possible to determine respiratory 
system resonant frequency by means of the forced oscillations technique (FOT).4 
In this study in each patient resonant frequency was measured by means of the 
FOT in order to apply OHFO at his or her specific resonant frequency. The aim of 
the study was to evaluate the effect of OHFO at respiratory system resonant frequen-
cy when combined with forced expiration manoeuvres (huffing) on tracheobronchial 
clearance. This was compared with the effect of huffing alone and huffing in combi-
nation with breathing exercises and postural drainage (FET). 
Methods 
Patients 
Eight patients with chronic bronchitis as defined by the Medical Research Council5 
took part in the study. Their mean age was 60 yrs (range 44-76 yrs). The mean 
forced expiratory volume in one second (FEV,) was 68 (SD ± 27)% predicted. The 
mean forced vital capacity (FVC) was 92 (SD ± 20)% predicted. The mean 
FEV1/FVC was 67 (SD ± 19)% predicted. The mean sputum production was 33 
(range 22-47) g wet weight per day. 
Study design 
On three separate days with at least two days in between the effect of the following 
three treatments was evaluated: (1) oral high frequency oscillation (OHFO); (2) 
huffing combined with breathing exercises and postural drainage (FET); (3) huffing 
alone (control). The sequence was determined in a randomized cross-over fashion. 
OHFO consisted of oscillations superimposed on tidal breathing during one 
period of 30 minutes. Every 5 minutes OHFO was interrupted to perform a few huffs 
(maximal forced expirations from mid-lung volume). If necessary the patients 
coughed. OHFO was applied at respiratory system resonant frequency. This frequen-
cy had been determined on the same day prior to radio-aerosol inhalation by means 
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of the FOT4 using the Oscillaire (Jones, USA). Resonant frequencies ranged from 
92-25 Hj. Sinewave oscillations were produced by a 20 cm bass loudspeaker (Philips 
AD 80602 W8) connected to a waveform generator (Exar, XR-8038). Stroke volume 
of the oscillations ranged from 60-250 ml. Oscillations were delivered to the subject 
through a SO cm semirigid tube (internal diameter 2.5 cm) attached to a mouthpiece. 
A side arm in the tube 
was connected to a hu­
midifier (see figure 1). 
The patients were sitting 
with the elbows resting 
on a table. No postural 
drainage was performed. 
FET was applied ac­
cording to standard pro­
cedures.6,7 Only two ex­
perienced physiothera­
pists participated in the 
study in order to stand­
ardize the treatment as Figure 1. Schematic diagram of OHFO - delivery system. 
much as possible. FET 
included postural drainage consisting of six positions, four lying on a tilted bed (15e 
head down) and two seated (leaning 45° forward and 30° backwards respectively). In 
every position the patient was instructed to start with diaphragmatic breathing. When 
the patient had relaxed sufficiently this was followed by thoracic expansion exercises 
and again diaphragmatic breathing. Then followed two huffs (maximal forced 
expirations from mid-lung volume) with chest compression alternated with relaxed 
diaphragmatic breathing. If necessary the patient coughed. FET was performed 
without aid. Prior to the start of the study the patient had been instructed by the 
physiotherapist to perform the FET. The duration of the FET session was thirty 
minutes. During FET the patient was breathing ambient air. 
The control treatment consisted of breathing humidified air for 30 minutes through 
the mouthpiece of the switched off OHFO-generator, while sitting with the elbows 
resting on a table. No postural drainage was performed. Every 5 minutes this was 
interrupted to perform a few huffs. If necessary the patient coughed. 
Any medication was continued unaltered. The clinical condition of the patients as 
judged by lung function tests had to be stable for at least six weeks prior to and 
during the study period. The patients were informed about the design and the aim 
of the study. Written informed consent was obtained. The study was approved by the 
Medical Ethics Committee of the University Hospital. 
Test parameters 
Tracheobronchial clearance was measured using a radio-aerosol technique.8 A 
monodisperse 5 μια "Tc-labelled polystyrene particle aerosol was inhaled under 
20 cm 
1 Γ 
encased 
loudspeaker 
50 cm 
sideport to humidifier 
open to atmosphere 
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standardized conditions. The radioactivity in the thorax was measured by means of 
two horizontally opposed scintillation detectors. One detector was placed in front of 
the seated subject and centred midway the sternum, and the other behind the subject 
and centred at the spinal column. Measurements were started directly after inhala­
tion of the radio-aerosol and repeated at regular intervals i.e. approximately every 20 
minutes up to 6 hours after inhalation and once more at 24 h after inhalation. As 
described by Pavia et. al.' the sum of the radioactivity count rates of the two detec­
tors was corrected for background activity, isotope decay and 24 h retention. The 
latter is considered to be an estimate of the aerosol deposition in the non-ciliated 
regions of the lung. The corrected count rate was expressed as a percentage of the 
count rate assessed immediately before the start of the treatment (OHFO, FET or 
control). These percentages were plotted against time after start of the treatment 
thus resulting in tracheobronchial retention curves. The area under the retention 
curves of each individual measurement was calculated using non-fitted data. 
The area under the retention curve up to 2.5 hours after start of the treatment 
(AUC-2.5) was used to evaluate the effect of the treatment.10 
Lung function was measured just before inhalation of the radio-aerosol and at 
about 1 hour after physiotherapy, including a flow volume curve and sGaw by means 
of a body Plethysmograph (Jaeger Bodyscreen U). Sputum was collected during the 
therapy, and during the rest of the day. Sputum wet weight was measured. In 
addition sputum was dried for 72 
hrs at 5(fC to determine sputum 
dry weight. The Wilcoxon test 
for paired data was used to eval­
uate the significance of any dif­
ferences observed. 
Results 
No significant difference between 
the values of 24 h retention after 
OHFO, FET or Control treat­
ment was found. The mean 24 h 
retention which stands for alveo­
lar deposition was 34 (SD ± 
18)%, 36 (SD ± 21)% and 35 
(SD ± 18)%. The mean curves 
of tracheobronchial retention 
after OHFO, FET and control 
are presented in figure 2. At 40 
and 60 minutes there is a signifi­
cant difference between FET and 
both OHFO and control 
(p<0.02). At 80 minutes there is 
a significant difference between 
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Figure 2. Mean tracheobronchial retention curves during 
and after control, OHFO and FET. 
• ρ < 0.02 FET vs OHFO and control 
χ p<0.QS FET vs OHFO. 
FET and OHFO only (ρ < 0.05). In table 1 the results of the area under the curve up 
to 2.5 hrs after the start of therapy (AUC-2.5) are presented. In all patients the 
AUC-2.5 was smallest after FET as compared with both OHFO and control 
(p<0.02). There appeared to be no significant difference in AUC-2.5 between OHFO 
and control. In table 2 the results of the measurement of lung function are presented. 
There appeared to be no consistent effect of any of the three therapies. The results 
of the measurement of the collected sputum are presented in table 3. Sputum 
production during FET was significantly (p<0.02) larger than during both OHFO 
and control. 
Table 1. Area under the curve 0-2.5 hours after start of therapy (AUC-2.5) 
(%hours) of each patient for FET, OHFO and control respectively. 
Patient No. FET OHFO control 
1 207 222 228 
2 66 103 184 
3 129 140 173 
4 162 185 189 
5 193 236 198 
6 109 229 194 
7 79 101 103 
8 209 213 220 
Mean 144 179 186 
SD 58 56 38 
Table 2. Lung function data before and after therapy (n = 8, mean ± SD). 
FEV, (1) 
FVC(l) 
MEF« 
(1/sec) 
sGaw 
(1/secJcPa) 
before after 
FET 
2.3 ±1.0 2.2+1.0 
4.0 ±1.1 3.8 ±1.1 
1.5 ±1.0 1.5 ±1.1 
0.77 ±0.36 0.76 ±0.44 
before after 
OHFO 
2.2 ±1.0 2.1 ±1.0 
3.9 ±1.0 3.6 ±1.0 
1.6 ±1.2 1.5 ±1.2 
0.69±0.25 0.72+039 
before after 
control 
2.3 ±1.0 2.2 ±1.0 
3.9 ±1.1 3.8 ±1.1 
15 ±1.0 1.6 ±1.1 
0.85 ±038 0.76 ±0.43 
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Table 3. Sputum production (η = 8, mean ± SD). 
FET OHFO CONTROL 
During therapy 201 ± 145* 43 ±62 29 ± 42 mg 
dry weight 
24 h production 36 ± 12 31 ± 10 32 ± 9 g 
wet weight 
* ρ < 0.02 as compared with OHFO and Control. 
¡Discussion 
The aim of this study was to evaluate the effect of OHFO on tracheobronchial 
clearance in patients with chronic bronchitis and abundant sputum production. In the 
study by George et al.1 resonant frequency was determined by the subjects themselves 
on the basis of their sensation of shaking within the chest. This frequency ranged 
from 8-12 Hj. In our study OHFO was applied at a predetermined frequency 
identical to respiratory system resonant frequency as measured by means of FOT. 
This ranged from 9.2 to 25 H,. Apart from the frequency of the oscillations, the 
volume thereof could be varied individually as well. The latter was adjusted in such 
a manner that it was possible to feel the oscillations by hand over the thorax of the 
patients or to hear them by stethoscope over the lungs without the oscillations 
causing too much discomfort to the patients. Apart from the oscillations OHFO in 
this study consisted of forced expiration manoeuvres at 5-minute intervals. George et 
al.1 suggest that the mechanism by which OHFO is effective in promoting mucus 
clearance is by altering the visco-elastic properties of airway mucus. King11 has 
reported that high frequency oscillation reduces the apparent viscosity of sputum in 
vitro. In the same study has been demonstrated that a decrease in mechanical 
impedance (i.e. the vectorial sum of elasticity and viscosity) of mucus appears to have 
a positive effect on clearance induced by in vitro simulated cough. Assuming that 
these results are also valid for forced expirations it seems logical to combine OHFO 
with forced expiration manoeuvres as performed in our study. However, the results 
reported by King have been questioned by Hachenberg et al.12 The latter reported a 
slight but significant increase in viscosity under high-frequency vibration. There 
appeared to be no significant difference in any of the parameters between OHFO 
and a control measurement, which consisted only of forced expiration manoeuvres at 
5-minute intervals for 30 minutes. FET including forced expiration manoeuvres, 
breathing exercises and postural drainage appeared to be significantly more effective 
than both OHFO and control (see figure 2 and table 1 and 3). Probably the most 
essential difference between FET and OHFO is postural drainage. In this respect it 
is important to realize that George et al. reported a significant enhancement of 
tracheobronchial clearance in cystic fibrosis patients only when OHFO was combined 
with physiotherapy including postural drainage.2 Although in our study essentially 
different equipment to generate oscillations has been used, our results of OHFO are 
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in agreement with those reported by Ravez et al.3 The fact that George et al.1 found 
an enhancement in tracheobronchial clearance caused by OHFO in normal subjects 
might suggest that OHFO can be beneficial only in the presence of normally effective 
mucociliary clearance and not in the presence of excessive bronchial secretions and 
/or failing mucociliary transport. The suggestion by the same authors that OHFO 
exerts its effect mainly in distal airways is not supported by the results in our study 
(see fig. 2). The difference between the study of George et al.1 and our study with 
regard to the time during which OHFO has been applied could provide an explana-
tion for the contradictory results. Several authors have described the effect of non-
symmetrical flow on mucus transport in vitro.13"15 This effect of oscillatory flow has 
been seen in an animal study in which dogs were ventilated by means of chest wall 
oscillation.16 The oscillations delivered to the subjects in our study were symmetrical. 
Furthermore, these oscillations were superimposed on spontaneous tidal breathing. 
Therefore the described mechanism13"13 by which nonsymmetrical flow causes mucus 
transport does not seem to be applicable to our results. 
On the basis of the results of our study it must be concluded that OHFO as 
applied in this study in combination with forced expiration manoeuvres does not 
improve tracheobronchial clearance of excessive bronchial secretions in patients with 
chronic bronchitis. 
Acknowledgements: This study was supported by a grant from the Dutch Asthma 
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Chapter VI 
No difference in effectiveness of a mucolytic, 
a hypertonic or an isotonic saline aerosol 
when combined with forced expiration manoeuvres 
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SUMMARY 
The purpose of this study was to evaluate the effect of an inhaled mucolytic in 
combination with the forced expiration technique (FET) on tracheobronchial 
clearance. Eight patients with chronic bronchitis and abundant sputum production 
inhaled on three separate days in a double blind randomized cross-over fashion one 
of the following nebulized solutions: 
(A) mercaptoethane sulphonate (MistabronR), (B) hypertonic saline, (C) isotonic 
saline. Clearance was measured using a radio-aerosol technique. 
There were no significant differences in tracheobronchial retention between 
aerosol А, В and С directly after inhalation and prior to the start of physiotherapy. 
After completion of FET there appeared to be no difference in tracheobronchial 
retention between the three treatments. 
It is concluded that there is no significant difference in effect of inhalation of 
MistabronR, hypertonic saline or isotonic saline when combined with FET including 
postural drainage in chronic bronchitics. 
M. van Hengstum, afdeling Longziekten, University Hospital Nijmegen, Geert Groote­
plein Zuid 8, p.o. box 9101, 6500 HB Nijmegen, The Netherlands. 
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Introduction 
Treatment with mucolytics is common practice in patients with troublesome expec­
toration. However, objective evidence for the effectiveness of inhaled mucolytic drugs 
in mobilizing excessive bronchial secretions is rather scarce.1,2 The supposed enhance­
ment of clearance by mucolytics is thought to be due to either reduction of the 
viscosity by breaking down disulphide bonds3 or to reduction of the consistency by a 
direct osmotic effect.1 This remains to be elucidated. 
The combination of inhaled mucolytics with chest physical therapy seems logical 
in order to achieve maximal clearance of excessive secretions. No study so far has 
evaluated the effect of this combmation on tracheobronchial clearance using an 
objective in vivo radio-aerosol technique. The aim of this study was to compare the 
effect of an inhaled mucolytic (Sodium mercaptoethane sulphonate) with that of a 
hypertonic and an isotonic saline aerosol, all three combined with a forced expiration 
technique (FET) session. 
Patients 
Eight patients with chronic bronchitis as defined by the Medical Research Council 
criteria4 took part in the study. Their mean age was 65 yrs. (range 52-73 yrs). The 
mean forced expiratory volume in one second (FEVj) was 86 (SD ±25)% predicted. 
The mean FEV^VCin % was 84 (SD ± 23)% predicted. The mean sputum produc­
tion was 39 g (range 18-83 g) per day. 
Study design 
On three separate days - with at least two days in between - the treatment consisted 
of the inhalation of an aerosol followed by a FET session. On each occasion in a 
double blind randomized order one of three different aerosol solutions (А, В and C) 
was nebulized by means of a jet nebulizer (Pari Inhalierboy11) and inhaled through a 
mouthpiece. Sterk et al have studied the output characteristics of several nebulizers.5 
The volume median aerodynamic diameter (VMADd) of the primary droplets 
produced by the Pari Inhalierboy11 appeared to be 3.5 μ m. 
In table 1 the composition and osmolality of these solutions is listed. The se­
quence of the applied solutions was determined in a double blind randomized cross­
over mode. 
The inhalation of the aerosol took 20-25 minutes and was followed by a FET session 
according to standard procedures.6 This included postural drainage consisting of six 
positions, four lying on a tilted bed (15° head down) and two seated (leaning 45° 
forward and 30° backwards respectively). In every position the patient was instructed 
to start with diaphragmatic breathing. When the patient had relaxed sufficiently this 
was followed by thoracic expansion exercises and again diaphragmatic breathing. 
Then followed two huffs (maximal forced expirations from mid-lung volume) with 
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Table 1. Composition and osmolality of the aerosol solutions. 
Solution Composition Osmolality 
(mOsm/1) 
A. Sodium mercaptoethane sulphonate 
(MistabronR) 400 mg 1125 
terbutaline sulphate 03 mg 
in sodium chloride 0.54% 5 ml 
B. terbutaline sulphate 0.5 mg 1090 
in sodium chloride 3.38% 5 ml 
С terbutaline sulphate 0.5 mg 
in sodium chloride 0.9% 5 ml 333 
chest compression alternated with relaxed diaphragmatic breathing. If necessary the 
patient coughed. FET was performed without aid. Prior to the start of the study the 
patient had been instructed by a physiotherapist to perform the FET. The duration 
of the FET session was thirty minutes. Only two experienced physiotherapists 
participated in order to standardize the treatment as much as possible. Medication 
was continued unaltered during the study, but mucolytic drugs were not allowed. The 
clinical condition of the patients had to be stable for at least six weeks prior to and 
during the study period. The patients were informed about the design and the aims 
of the study. Written informed consent was obtained. The study was approved by the 
Medical Ethics Committee of the University Hospital. 
Test parameters 
Tracheobronchial clearance was measured using a radio-aerosol technique.7 A 
monodisperse 5 ßm "Tc-labelled polystyrene particle aerosol was inhaled under 
standardized conditions. The radioactivity in the thorax was measured by means of 
two horizontally opposed scintillation detectors. One detector was placed in front of 
the seated subject and centred at the sternum, and the other behind the subject and 
centred at the spinal column. Measurements were started directly after inhalation of 
the radio-aerosol and repeated directly prior to and after inhalation of aerosol A, В 
or C, and directly after the FET session. Up to several hours after the start of the 
inhalation of the aerosol measurements were repeated at 30-minute intervals and 
once more at 24 h after radio-aerosol inhalation. As described by Pavia et.al.8 the 
sum of the radio-activity count rates of the two detectors was corrected for back­
ground activity, isotope decay and 24 h retention. The latter is considered to be an 
estimate of the aerosol deposition in the non-ciliated regions of the lung. The 
corrected count rate was expressed as a percentage of the count rate assessed 
immediately before the start of the inhalation of aerosol А, В or С These percen­
tages were plotted against time after the start of inhalation of aerosol А, В or C, thus 
resulting in tracheobronchial retention curves. 
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Lung function was measured just before inhalation of the radio-aerosol and at 
about 1 hour after physiotherapy, including a flow volume curve and sGaw by means 
of a body Plethysmograph (Jaeger Bodyscreen II). Sputum was collected during the 
FET session, and during the rest of the day. Sputum wet weight was measured. In 
addition sputum was dried for 72 h at 50oC to determine sputum dry weight. The 
WUcoxon test for paired data was used to evaluate the significance of any differences 
observed. 
Results 
No significant differences between the values of 24 h retention of the radio-aerosol 
after the mucolytic, hypertonic or isotonic saline aerosol were found. The mean 24 
h retention which represents alveolar deposition was 43 (SD ± 24)%, 44 (SD ± 
19)% and 44 (SD ± 16)% respectively. 
The mean curves of 
tracheobronchial reten-
tion during and after 
the mucolytic, the hy-
pertonic and isotonic 
aerosol are presented 
in the figure. With 
respect to the tracheo-
bronchial retention at 
30 min. and 60 min. 
after the start of the 
inhalation of the aero-
sol i.e. after completion 
of the inhalation (30 
min.) and after the 
FET session (60 min.) 
there appeared to be 
no significant difference 
in tracheobronchial 
retention between the 
three treatments. At 2 
h after the start of 
inhalation of the muco-
lytic, the hypertonic 
and the isotonic aerosol 
the tracheobronchial 
retention appeared to be 25 (SD ± 9)%, 19 (SD ± 11)% and 24 (SD ± 17)% 
respectively, being not significantly different. 
The results of the lung function measurement before and after treatment are 
listed in table 2. There appeared to be no significant difference between the effects 
of the three treatments. Statistical significance was reached only for the results of the 
66 
Tracheobronchial retention 
100 
90 
80 
70 
60 
50 
¿0 
30-
20-
10 
0 
Aerosol Physiotherapy 
0 30 60 
Time after start inhalation aerosol(min.) 
Mistabron Hypertonic Isotonic 
Figure 1. Mean tracheobronchial retention curves during and after the 
mucolytic (0-0), the hypertonic ( t - · ) and the isotonic (+—+ ) aerosol. 
measurement of FEVt and sGaw after inhalation of hypertonic saline as compared 
with those before inhalation. The results of the measurement of sputum wet and dry 
weight are listed in table 3. The differences between the three treatments are not 
statistically significant. 
Table 2. Lung function data before and after aerosol inhalation combined with FET 
(n = 8). 
MIST. 
before after 
HYPERT. 
before after 
ISOTON. 
before after 
Mean FEV! (1) 
SD 
Mean FVC Q) 
SD 
Means sG«, 
SD 
(kPa-sec)1 
2.08 
0.8 
3.2 
0.8 
0.789 
0.26 
2.19 
1.0 
33 
1.0 
0.876 
0.32 
2.09 
0.7 
3.2 
07. 
0.809 
037 
230* 
0.7 
3.4 
0.7 
0.991** 
0.39 
2.07 
0.7 
3.2 
0.8 
0.829 
033 
2.15 
0.8 
3.1 
0.8 
1.08 
0.53 
' ρ < 0.05 as compared with the FEV, before treatment 
*· ρ < 0.02 as compared with the sG^, before the treatment. 
Table 3. Data on sputum production (mean ± SD), (η = 8). 
Mistabron Hypertonic 
saline 
Isotonic 
saline 
sputumproduction during FET 
wet weight (g) 7.8 ± 63 6.9 ± 23 6.1 ± 3.5 
dry weight (mg) 120±120 132 ±98 125±102 
24 h sputum production 
wet weight (g) 37.7 ± 18 36.5 ± 10 43 ± 24 
Discussion 
In the present study no statistically significant differences between the effect on 
tracheobronchial clearance of treatments consisting of inhalation of three different 
aerosols (a mucolytic drug, a hypertonic and an isotonic saline solution) followed by 
FET could be found. 
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Clarke et al.' reported an enhancement in tracheobronchial clearance in chronic 
bronchitics after inhalation of Mistabron1*, however the difference was not statistically 
significant. In the same study the inhalation of hypertonic saline (7.1%) appeared to 
be more effective than Mistabron" though. They suggested that the enhanced 
clearance after the hypertonic saline aerosol was due to a local osmotic effect 
resulting in water being drawn into the airway lumen. In this context it must be 
pointed out that in our study solution В consisted of a much weaker saline solution 
i.e. 3.38% (see also table 1). A possible osmotic effect therefore would have been 
less than in the study reported by Clarke et al.1 In another study2 an improvement in 
pulmonary function was found in patients with cystic fibrosis after an eight-week 
course of intermittent MistabronR inhalation. This effect was not seen after inhalation 
of iso-osmolar hypertonic saline (7%). There were no changes in cough frequency, 
sputum volume, sputum bacteriology or symptom scores. In our study in patients with 
chronic bronchitis no significant differences in tracheobronchial retention were found 
after inhalation of MistabronR, hypertonic and isotonic saline. All three aerosol 
solutions contained 0.5 mg terbutaline. This drug was added in order to prevent 
bronchoconstriction.9 Subcutaneously administered ß-mimetic drugs stimulate 
mucociliary clearance.10,11 Reports on the effect of inhaled ß-mimetic drugs on 
tracheobronchial clearance show conflicting results. Pavia et al.12 utilizing exactly the 
same technique for measuring clearance as used in our department, failed to 
demonstrate an effect of inhaled terbutaline on mucociliary clearance. Foster et al.13 
and recently Weich et al.14 - using a different technique - described the enhancement 
of clearance after inhalation of isoproterenol and fenoterol respectively. In our study 
solution С containing terbutaline and sodium chloride 0,9% was meant to serve as a 
control measurement in order to evaluate the effect of the hypertonic solutions A 
and В (see table 1). The differences in tracheobronchial retention after inhalation of 
Mistabron, hypertonic saline and isotonic saline before physiotherapy was started, 
appeared to be not significant. After FET was completed retention was practically 
identical, suggesting that any difference in effectiveness of any of the three aerosols 
had been annihilated by a physiotherapy session, including postural drainage. 
The forced expiration technique combined with postural drainage has been shown 
to be an effective means of accelerating clearance of excess bronchial secretion.15,16 
Means of improving this effect have been studied by Sutton et al.17 They reported 
that the use of nebulized terbutaline immediately before FET enhanced clearance 
significantly more than FET alone. The amount of terbutaline nebulized in their 
study was S mg as opposed to 0.5 mg in our study . 
After the inhalation of all three aerosols followed by FET lung function variables 
showed an improvement. After inhalation of hypertonic saline followed by FET there 
was a statistically significant improvement in FEV1 and sGaw. In our former study
16 
we did not find an improvement in lung function at all. Therefore the improvement 
in lung function in the present study is probably due to the inhalation of terbutaline. 
The results of the measurement of sputum production are in agreement with 
those of the measurement of radioaerosol clearance, i.e. no significant differences 
were found between the three treatments. Inhalation of the hypertonic solutions A 
and В did not result in a significantly larger amount of sputum. Therefore there are 
no indications for a possible osmotic effect caused by the hypertonic aerosols. It is 
68 
concluded that there is no significant difference in effect on tracheobronchial 
clearance of inhalation of MistabronR, hypertonic saline or isotonic saline when 
combined with a FET session including postural drainage. 
This study was supported by a grant from the Dutch Asthma Foundation (no. 86.07). 
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ABSTRACT 
In б patients with dextrocardia (DC) tracheobronchial clearance was measured by 
means of a radio-aerosol technique (5 micron T c labelled polystyrene particles). 
The retention curves were corrected for expectorated sputum in order to rule out as 
much as possible the effect of so-called cough clearance. In 2 patients clearance after 
sputum correction was practically absent, i.e. 6 hours after inhalation there was 82 
and 83% tracheobronchial retention. In the remaining 4 patients this was 56, 55, 46 
and 42%. The mean tracheobronchial clearance of all DC patients was significantly 
slower than the mean clearance of 10 healthy non-smoking subjects, but not signifi­
cantly different from that of 6 patients with chronic bronchitis, who were all current 
smokers. It is concluded, that in some patients with dextrocardia, Kartageners 
patients included, there exists a decreased, but effective clearance, even after 
correction for cough clearance. 
M. van Hengstum, afdeling Longziekten, University Hospital Nijmegen, Geert Groote-
plein Zuid 8, p.o. box 9101, 6500 HB Nijmegen, The Netherlands. 
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Introduction 
In 1933 Kartagener described four patients presenting with the combination of situs 
inversus, sinusitis and bronchiectasis.1 This triad is referred to as Kartageners 
syndrome (KS). Originally the bronchiectases in these patients were thought to be 
congenital. Today it is a widely accepted view, that they are caused by recurrent 
purulent respiratory tract infections. KS appears to be associated to a high degree 
with infertility, although there have been several reports of KS patients with descend-
ants.2"5 The first reports of sperm tail immotility focused attention on ciliary abnor-
malities as a possible cause of the recurrent respiratory tract infections.6 Since 1976 
several specific abnormalities in the cihary ultrastructure associated with ciliary 
immotility or dyskinesia have been reported in KS patients.7'13 Also KS patients with 
normal cilia have been described.14,13 In conclusion there appears to exist a whole 
spectrum of congenital ciliary abnormalities of both structure and function. Muco-
ciliary clearance is thought to be an important host defence mechanism of the 
respiratory tract. Absence of mucociliary clearance is considered to be a hallmark of 
the primary ciliary dyskinesia syndrome.16 It is therefore difficult to understand, why 
patients with the primary ciliary dyskinesia syndrome, KS patients included, appear 
to have a relative good life expectancy. It has been suggested by Afzelius, that ciliary 
malfunction in the embryonic phase causes situs inversus in half the patients in a 
randomized fashion.17 This would imply that every patient with situs inversus, 
including dextrocardia, must have congenital ciliary malfunction. 
The aim of this study was to establish the presence or absence of tracheobron-
chial clearance other than caused by cough in patients with dextrocardia. For this the 
radio-aerosol technique described by Thomson and Short" was used. The results of 
the DC patients were compared with those of healthy non-smoking subjects and 
those of patients with chronic bronchitis (CB). 
Patients 
Six patients with dextrocardia were investigated. Dextrocardia is defined as lateral 
transposition of the viscera of the thorax. Individual lung function data are listed in 
table 1. 
Table 1. Individual lung function data of the DC patients. 
Patient 
No. 
1. 
2. 
3. 
4. 
5. 
6. 
FVC 
(litre) 
3.0 
4.5 
5.5 
2.7 
5.0 
2.6 
(%pred.) 
(91) 
(79) 
(101) 
(73) 
(91) 
(68) 
FEW, 
(litre) 
1.6 
2.7 
4.5 
1.8 
4.1 
1.4 
(%pred.) 
(60) 
(58) 
(108) 
(67) 
(93) 
(57) 
FEVj/FVC 
(%) 
53 
59 
82 
68 
83 
54 
(%pred. 
(80) 
(81) 
(76) 
(74) 
(81) 
(65) 
72 
Only patient no.l was current smoker, i.e. smoked very rarely. Patient no. 6 was ex-
smoker with 49 pack-years. The remaining 4 DC patients were all non-smokers. All 
patients, except patient no. 6, did have both upper (ENT) and lower respiratory tract 
symptoms. Individual clinical data of the DC patients are listed in table 2. 
Table 2. Individual clinical data of dextrocardia patients. 
Patient Sputum culture Bronchography 
No/Age/Sex 
1 / 20 / F Hem. Infi. ectases left+ right side 
2 / 17 / M Hem. Infl./Strept.Pneum. ectases left lower lobe 
3 / 24 / M Hem. Infl./Strept.Pneum. ectases left lower + middle lobe 
4 / 38 / F Hem. Infl. 
5 / 16 / M Hem. Iiifl./Strept.Pneum. no visualization of middle lobe + lingula 
6 / 66 / M negative no ectasis 
For comparison of tracheobronchial clearance results the data of six patients with 
chronic bronchitis were used, who were matched for 24h retention. Chronic bron-
chitis was defined according to the MRC criteria.19 These patients were all current 
smokers. The mean number of pack-years was 29.6. The mean age was 58 years, 
ranging from 37 to 67 years. 
Results of the DC patients were also compared with those of 10 healthy non-
smoking individuals. 
From all patients a signed informed consent was obtained. 
Methods 
Using a spinning disc generator (R.E. May Spinning Top aerosol generator, Research 
Engineers Ltd.) a " T c labelled monodisperse 5 micron polystyrene aerosol was 
produced. This aerosol was inhaled under standardized conditions, i.e. 15 inhalations 
of 450-500 ml each. The subjects were asked to inhale slowly. There was a 3 seconds 
breath-holding pause after each inhalation. After inhalation the radioactivity in the 
thorax was measured at regular intervals for 6 hours by means of two horizontally 
opposed scintillation detectors consisting of thallium activated sodium-iodide (Nal) 
crystals. One detector was positioned in front of the seated subject centred midway 
the sternum and the other behind the subject centred at the spinal column. Inter-
ference of activity present in stomach or throat with the measurement of activity 
present in the lungs was reduced to a minimum by using collimators with an aperture 
of 9.0 cm diameter at 2.5 cm from the crystal. At 24 hours after inhalation radioacti-
vity was measured once more. This measurement is supposed to be an estimate of 
radioaerosol deposition in the non-ciliated regions of the lungs, which is also referred 
to as "alveolar deposition". The sum of the radioactivity count rates of the two 
detectors was corrected for background activity and isotope decay. The tracheobron-
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chial clearance was then estimated by correcting for 24 h retention. The tracheobron­
chial retention curve was obtained by plotting tracheobronchial retention (TBRet), 
expressed as percentage of initial tracheobronchial deposition, against time after 
inhalation (PIT). During the measurement patients were allowed to cough. They 
were encouraged to expectorate sputum, when coughing was productive, rather than 
swallowing it. As described by Pavia et al20 tracheobronchial retention was corrected 
for activity measured in expectorated sputum. Coughs were recorded and radio­
activity of the sputum samples was measured on a separate Nal crystal (N counts). 
In order to correct the decrease in intrathoracic activity for the effect of coughing 
with expectoration of sputum a correction factor was calculated. By means of this 
correction factor the number of counts measured in the sputum samples was 
converted to an equivalent number of counts of intrathoracic activity. In this way the 
radioactivity which was expectorated was added back to the intrathoracic activity. For 
the calculation of the correction factor first a " T c source was measured (A counts) 
in the same way as sputum samples were measured. Subsequently this source was 
positioned in the trachea of a phantom of the thorax (RT-200 phantom, Humanoid 
Systems). This "intrathoracic" activity was measured (B counts) in the same way as 
this was done in the subjects. After correction for physical decay this number of 
counts (B) was divided by the number of counts in the first measurement (A). 
Therefore in case there had occurred expectoration of any sputum д· χ N counts were 
added back to the counts of intrathoracic activity. 
Five patients (nos 1-5) did not take any medication on the day of the measurement. 
Patient no. 6 had the following medication: beclomethasone dipropionate, theophylline, 
salbutamol, dipyridamole and Clonidine. The mean of the tracheobronchial retention 
curves was calculated using the interpolated percentages at twenty minute intervals 
of the individual curves. The two-sample Wilcoxon test was used to evaluate the 
significance of any observed differences between the different groups of patients. 
Results 
In figures 1-6 individual tracheobronchial retention curves are presented. The arrows 
in the curves indicate the coughs during the measurement in the individual patients. 
Patient no. 3 had a cough twice during the measurement. This patient was capable 
of indicating exactly when he had to cough. Thereby it was possible to measure the 
intrathoracic activity directly before and after coughing. In table 3 individual data of 
percentage tracheobronchial retention (TBRet.) at 6 hours after inhalation (6h PIT) 
and of the percentage 24h retention (24h ret.) are listed. The mean 24h retention of 
the 6 DC patients was 49% (SD ± 19%). For the 6 CB patients this was 50% (SD 
± 17%) and for the healthy non-smoking subjects 52% (SD ± 10%). The mean 
tracheobronchial retention curves of all DC patients, uncorrected and "sputum 
corrected", of the chronic bronchitis patients and of the healthy subjects are 
presented in fig. 7. The mean TBRet. at 6h after inhalation of the б DC patients, 
uncorrected for expectoration, was 48%. "Corrected for sputum" this was 61%. The 
mean TBRet. at 6h after inhalation of the б chronic bronchitis patients and of the 10 
healthy subjects was 41 and 18 respectively. 
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Figure 1-6. Individual tracheobronchial retention curves of dextrocaidia patients, uncorrected and 
corrected for expectorated sputum. 
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Table 3. Tracheobronchial retention data of the DC patients. 
Patient 
No. 
1 
2 
3 
4 
5 
6 
TBRet.(*)at 
6h PIT.C*) 
82 
43 
67 
24 
40 
29 
TBRet.(*) at 6h PIT.(**) 
"sputum corrected" 
24h ret. (•**) 
(%) 
82 
56 
83 
55 
46 
42 
29 
22 
71 
58 
59 
55 
• TBRet. = tracheobronchial retention 
*• PIT. = post inhalation time 
* · · 24h ret.= 24 hour retention 
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Figure 7. Calculated mean tracheobronchial retention curve (χ ± SEM) of dextrocardia patients 
(uncorrected and corrected for expectorated sputum) (n=6), of chronic bronchitis patients (n=6 and 
healthy individuals (n = 10). 
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There was no statistically significant difference between the mean of the uncorrected 
tracheobronchial retention curve of the DC patients and the mean curve of the 
chronic bronchitis patients (p > 0.1). Obviously clearance of the DC patients after 
"correction for expectorated sputum" is slower, but still not significantly different 
from the CB patients either (p > 0.1). The mean of the "sputum corrected" and the 
uncorrected clearance curves of the DC patients were both significantly different 
from the mean retention curve of the healthy subjects (p < 0.05). 
Discussion 
In six patients with dextrocardia the tracheobronchial clearance rate was measured. 
Patients no's 1-5 have a classical Kartagener's syndrome. Patient no. 6 has bronchitis 
only since 5 years, which can be explained by the fact, that he has been smoking for 
many years. This patient did not have nasopharyngeal complaints. Furthermore he 
has 2 children. This patient nevertheless was included in the study because as stated 
in the introduction according to Afzelius' hypothesis every patient with dextrocardia 
must have some form of congenital ciliary malfunction. 
As shown in figure 7 the mean clearance of the CB patients is not significantly 
different from the mean uncorrected clearance of the DC patients and neither from 
the mean of the "sputum corrected" clearance of the DC patients. The mean 
tracheobronchial clearance of the healthy non-smoking subjects is significantly faster 
than the other curves. The CB patients were older than the DC patients. The mean 
age was 58 and 30 years respectively. As reported by Puchelle clearance rate declines 
with age.21 Furthermore it should be taken into consideration that all CB patients 
were current smokers. Four DC patients were non-smokers. Long-term smoking 
impairs tracheobronchial clearance.22 Comparing the results of the measurement of 
tracheobronchial clearance of the DC patients with those of the CB patients these 2 
factors, age and smoking habit, should be taken into account. In patients no.l and 3 
tracheobronchial clearance was severely impaired or absent, being in accordance 
with views and data in üterature. However in the remaining 4 patients there exists 
obvious tracheobronchial clearance, even after correcting for cough. 
Tracheobronchial clearance was measured for б hours. It is practically impossible for 
these patients not to cough for such a long period. The main problem was therefore 
to correct for so-called cough clearance. Sometimes part of the sputum is swallowed. 
Consequently cough clearance will be underestimated. It is possible that this may 
have occurred sometimes. However, correcting for expectorated sputum in the 
manner described above leads in itself to an underestimation of the effect of tracheo­
bronchial clearance other than by coughing. Because this correction implies that 
activity present in sputum would not have been cleared at all otherwise. Which 
mechanism could explain the observed clearance in four of the б DC patients? 
According to the literature two possible mechanisms responsible for tracheobronchial 
clearance other than by cough and/or mucociliary clearance are two-phase gas-liquid 
interaction and stop and go transport in peripheral airways. In vitro studies suggest, 
that two-phase gas-liquid interaction may be of importance in patients with abundant 
bronchial secretion.23,24 It remains to be proven though whether this mechanism is 
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effective in vivo. Another interesting phenomenon has been described as stop and go 
particle transport in the peripheral airways.25 This implies unidirectional transport of 
particles in a fluid film solely under the influence of compression and expansion of 
this fílm. The effectiveness of this mechanism in vivo needs confirmation also. 
Finally the results of this study seem to stress the necessity of both EM examina-
tion and dynamic studies of coordination and beat frequency of bronchial cilia in 
these patients. 
In conclusion the results of this study are in agreement with those reported by 
Pavia et al.20 They indicate, that in some patients with dextrocardia, including patients 
with Kartagener^ syndrome, there exists a decreased but effective tracheobronchial 
clearance which can not be attributed to coughing alone. 
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Introduction 
The rehabilitation program for patients with pulmonary diseases in the University 
Lung Centre Nijmegen included the regular use of sauna. Many patients with chronic 
bronchitis and abundant sputum production indicated that during or after sauna 
expectoration seemed to be improved. It appeared therefore that sauna might 
provide an alternative for chest physical therapy with regard to clearance of excessive 
bronchial secretions. Therefore a study was performed to evaluate the effect of sauna 
on tracheobronchial clearance in chronic bronchitics. 
Patients and methods 
Five male patients with chronic bronchitis according to the MRC criteria1 took part 
in the study. Their mean age was 52 yrs (range 41-67 yrs). The mean forced expira­
tory volume in one second (FEV,) was 69 (SD ± 9)% predicted. The mean vital ca­
pacity was 92 (SD ± 14)% predicted. Tracheobronchial clearance was measured by 
means of a radio-aerosol technique as described in more detail in an earlier publica­
tion2. A 5 μ m "Tc-labelled polystyrene particle aerosol was inhaled under standard­
ized conditions. Subsequently intrathoracic radioactivity was measured at regular inter­
vals by means of two scintillation detectors. As described by Pavia et al3 the sum of 
the radioactivity count rates of the two detectors was corrected for background activity, 
physical decay of the radionuclide and 24 h retention. The tracheobronchial retention 
curve was obtained by plotting the percentages retention against time. The mean 
tracheobronchial retention curve was obtained using the interpolated percentages of 
the individual retention curves at twenty minute intervals. The last measurement prior 
to sauna or in the control measurement an equivalent span of time after inhalation 
of the radio-aerosol was defined as t0 i.e. approximately 30 minutes after inhalation. 
Tracheobronchial retention is expressed as percentage of activity measured at t0. 
In a randomized cross-over fashion tracheobronchial clearance was measured on 
two separate days. During one of these measurements the patients attended a stand­
ardized sauna program. Immediately after t0 patients went into the sauna for one and 
a half hours. No measurements were performed during this period. After completion 
of the sauna program the measurement of tracheobronchial clearance was resumed 
for approximately 2 hours. The other measurement of tracheobronchial clearance 
served as a control. The sauna program included two identical cycles. Each cycle 
began with a hot shower followed by a ten minute stay in the hot cabin (air tempera­
ture ± 90oC, relative humidity ± 15%). Then the subjects had a cold shower and 
underwent 3 immersions in a cold water basin. This was followed by a resting period 
(±15 min.). The Wilcoxon test for paired data was used to evaluate the significance 
of any differences observed. 
Results 
The mean tracheobronchial retention curves of the two measurements (sauna and 
control) are presented in the figure. No significant differences were observed 
between the two measurements. 
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TRACHEOBRONCHIAL RETENTION 
n = 5 
X+SEM 
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time (hrs) —» 
и = lost measurement before start of sauna 
о sauna 
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Tracheobronchial retention during and after sauna and during a control measurement in 5 patients with 
chronic bronchitis. 
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Conclusion 
It is concluded that sauna does not enhance tracheobronchial clearance in patients 
with chronic bronchitis. Therefore sauna can be no substitute for chest physical 
therapy. 
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Final discussion 
On the basis of the results of the study described in chapter Π it is concluded that 
tracheobronchial clearance in healthy non-smoking subjects has considerable inter-
subject variability. Is there an explanation for the rather large variability between 
subjects? One explanation could be the difference in deposition pattern between 
individuals as a consequence of differences in anatomy and mode of inhalation of the 
radio-aerosol. Another variable is ciliary beat frequency. Duchateau et al1 reported 
a significant correlation between nasal ciliary beat frequency and nasal mucus 
transport rate in healthy volunteers. It seems plausible that the same correlation 
exists for mucociliary transport rate in the lower airways. Furthermore the rheolog-
ical characteristics of bronchial secretion probably play a role in individual clearance 
rate also. However, little is known about this relationship, not surprisingly, because 
the assessment of rheological properties of respiratory mucus in healthy subjects is 
difficult. 
In the chapters Ш- І studies are described on the efficacy of several physiothera­
peutic interventions. One could argue that the number of patients included in these 
studies is rather small. On the basis of the data listed in table 3 of chapter Π it can 
be concluded that a number of 8 subjects is sufficient to detect a 10% difference in 
tracheobronchial clearance at 2 hours after the start of the measurement and/or in­
tervention. These numbers are based on the results of the measurement of tracheo­
bronchial clearance in healthy individuals though. It is well known from the literature 
that variability of tracheobronchial clearance is larger in patients with chronic 
bronchitis. So the minimum change in tracheobronchial clearance due to a particular 
intervention must be somewhat larger than 10% in order to be detected in a cross­
over trial including 8 subjects. As it was decided that for this type of treatment a 
direct effect amounting to at least 15-20% increase or decrease of tracheobronchial 
clearance must be considered as being clinically relevant, a number of 8 subjects 
seems to be sufficient. 
The results of the studies described in the chapters Ш- show that postural drainage 
is a very important component of chest physical therapy. However, patients experien-
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ce postural drainage as rather unpleasant. McDonnell et al2 reported that during 
chest physiotherapy including postural drainage in patients with cystic fibrosis, 
significant desaturations occurred. Desaturation could not be prevented by supple­
mental oxygen. The authors concluded that a possible explanation could be an 
increase in ventilation-perfusion mismatch due to blocking of airways by mucus plugs. 
It is therefore understandable that clinicians and physiotherapists are looking for 
alternatives to improve bronchial drainage effectively without the need of postural 
drainage. However, the results of the studies described in chapters Ш- imply, that 
bronchial drainage procedures should include, if possible, postural drainage. Further­
more the combination of postural drainage and the forced expiration technique 
should be preferred for treatment of patients requiring regular (daily) chest physical 
therapy. It seems important to realize also that the duration of any bronchial 
drainage procedure should be limited in view of good so-called patient compliance. 
In chapter VI a study on the efficacy of an inhaled mucolytic in combination with the 
forced expiration technique is described. As mentioned in the discussion of this 
chapter the results suggest that any difference in effectiveness of any of the three 
aerosol solutions has been annihilated by the subsequent forced expiration technique 
session which was combined with postural drainage. It seems therefore interesting 
to repeat a similar study without the physical therapy component. Such a study 
should preferably include a control measurement i.e. without any treatment. In our 
study a design including aerosol treatment combined with a bronchial drainage 
procedure was chosen because this is a frequently applied combination in clinical 
practice. 
In recent years an increasing number of studies has been published with regard to 
primary ciliary dyskinesia. It has become clear that this syndrome consists of several 
types of anatomical and functional abnormalities of the mucociliary transport system. 
In the light of Alzelius' hypothesis patients with dextrocardia by definition are 
suffering from primary ciliary dyskinesia. Some of these patients indeed show the 
classical Kartagener's syndrome. In other patients, this is less evident. Investigations 
of these patients, as recommended in the discussion of chapter Ш, are possible 
only in well equipped laboratories and are not part of daily routine. Sometimes the 
implications of such investigations seem to be trivial. Therapeutic strategy usually is 
not influenced by the results thereof. For individual patients it can be of importance 
to know the chance of having descendants. 
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Summary 
In chapter I a brief review of the literature on tracheobronchial clearance is pre­
sented. Physiological aspects like structure and function of airway epithelium, 
mucociliary transport and cough are reviewed (section 1.1). Aspects of tracheobron­
chial clearance in several disease states are discussed in section 1.2. Techniques for 
the measurement of tracheobronchial clearance, which have been described in the 
past, and the technique, which was used in our laboratory, are discussed in section 1.3 
and section 1.4. Briefly, this technique implied the inhalation of a radio-aerosol, 
consisting of S μ m ""Tc labelled posystyrene particles. After mhalation intrathoracic 
radioactivity was measured at regular intervals by means of two scintillation detec­
tors. The decrease in intrathoracic radioactivity, corrected for physical decay, 
background activity and alveolar deposition, was assumed to reflect tracheobronchial 
clearance. In section 1.4 an outline of the study is presented also. 
The first study, which is described in chapter Π, deals with the variability of tracheo­
bronchial clearance in healthy non-smoking subjects. Clearance was measured twice 
in ten volunteers to evaluate both inter- and intrasubject variability. For the measure­
ment of tracheobronchial clearance the radioaerosol technique described in section 
1.4 was used. 
Several parameters were used to quantitate the results of this measurement. 
Among those was the area under the retention curve up to б hours after inhalation 
(AUC-6). The intersubject coefficient of variation (COV) using this parameter was 
31%. The intrasubject COV of the AUC-6 was 11%. These results compare favour­
ably with those reported by others using different techniques. It is concluded that the 
intrasubject variability of tracheobronchial clearance as measured by this technique 
is small. Furthermore studies, in which tracheobronchial clearance is used as a 
parameter, should preferably be of the cross-over type. 
In the first study (chapter Ш) on the effect of physiotherapeutic interventions on 
tracheobronchial clearance two frequently used regimens were compared with each 
other: conventional chest physiotherapy and the forced expiration technique. Conven­
tional physiotherapy included postural drainage, percussion and directed coughing. 
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The forced expiration technique included breathing exercises, huffing, if necessary 
coughing and postural drainage. Eight patients (six with cystic fibrosis and two with 
agammaglobulmaemia) took part in the study. Both techniques appeared to be 
equally effective with regard to tracheobronchial clearance, regional lung clearance, 
sputum production and lung function. Because the forced expiration technique after 
proper instruction and training can be performed without an assistant, this technique 
seems preferable in daily routine. 
In chapter IV two studies are described, both on positive expiratory pressure mask 
physiotherapy. In a randomized cross-over trial (section Г .1.), including a control 
measurement, the effect of positive expiratory pressure mask physiotherapy and of 
the forced expiration technique on tracheobronchial clearance was evaluated in eight 
chronic bronchitics with abundant sputum production (mean 32 g/day). Positive 
expiratory pressure mask physiotherapy included positive expiratory pressure mask 
breathing interspersed with breathing exercises, huffing and if necessary coughing, 
but no postural drainage. The forced expiration technique included breathing 
exercises, huffing and if necessary coughing combined with postural drainage. 
Clearance was measured by means of the radio-aerosol technique described in 
section 1.4. At 40 min. after the start of therapy the mean clearance, expressed as 
percentage of the amount of radioactivity present at the start of therapy, was 32% 
after positive expiratory pressure mask physiotherapy, 53% after the forced expiration 
technique session, and 15% in the control run. These differences were statistically 
significant (P<0.02). Sputum production during positive expiratory pressure mask 
physiotherapy and the forced expiration technique session was larger than during the 
equivalent period of time in the control run. It is concluded that both positive 
expiratory pressure mask physiotherapy and the forced expiration technique enhance 
tracheobronchial clearance. Furthermore it appeared that the forced expiration 
technique, combined with postural drainage is more effective than positive expiratory 
pressure mask physiotherapy. 
In the following section (Г .2.) the effect of positive expiratory pressure mask 
physiotherapy on regional lung clearance is evaluated. Regional lung clearance was 
estimated by means of gamma camera imaging. The results after positive expiratory 
pressure mask physiotherapy were not significantly different from control. The mean 
clearance in all three lung zones (peripheral, intermediate and inner) was largest 
after the forced expiration technique session including postural drainage. Statistical 
significance (p < 0.02) was reached only for clearance after the forced expiration 
technique in the inner region. It is concluded that positive expiratory pressure mask 
physiotherapy has no demonstrable effect on regional lung clearance. 
A study in which the effect of oral high frequency oscillation on tracheobronchial 
clearance was evaluated is described in chapter V. In a randomized cross-over trial 
including a control measurement oral high frequency was compared with the forced 
expiration technique. Eight patients with chronic bronchitis were investigated (mean 
sputum production 33 + 9 g/day). Oral high frequency oscillation was applied at the 
respiratory system resonant frequency of each patient (range 9-25 Hz) and combined 
with huffing. The forced expiration technique included breathing exercises, huffing, 
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if necessary coughing and postural drainage. Tracheobronchial clearance was 
measured by means of the radio-aerosol technique described in section 1.4. At 60 
minutes after start of the treatment mean tracheobronchial retention, expressed as 
percentage of the activity at the start of the treatment, was 70 ± 26% after oral high 
frequency oscillation, 54 ± 26% after the forced expiration technique session and 76 
± 18% in the control run, which included huffing only. Oral high frequency appeared 
to be not significantly different from control. The forced expiration technique was 
significantly different (p<0.02) from both OHFO and control. It is concluded that 
oral high frequency oscillation has no effect on tracheobronchial clearance in chronic 
bronchitics. 
The effect of an inhaled mucolytic in combmation with the forced expiration techni­
que on tracheobronchial clearance was investigated in the study described in chapter 
VI. Eight patients with chronic bronchitis and abundant sputum production inhaled 
on three separate days in a double blind randomized cross-over fashion one of the 
following nebulized solutions: (A) mercaptoethane sulphonate (MistabronR), (B) 
hypertonic saline and (C) isotonic saline. Inhalation of each solution was followed by 
a forced expiration technique session. Clearance was measured using the radio-
aerosol technique described in section 1.4. No significant differences between the 
three treatments were found. It is concluded that there exists no significant difference 
in effectiveness of inhalation of MistabronR, hypertonic saline or isotonic saline when 
combined with a forced expiration session including postural drainage. 
Tracheobronchial clearance in patients with dextrocardia is reported in chapter П. 
In six patients with dextrocardia tracheobronchial clearance was measured by means 
of the radio-aerosol technique described in section 1.4. The tracheobronchial reten­
tion curves were corrected for expectorated sputum in order to rule out as much as 
possible the effect of cough-clearance. In two patients clearance after sputum 
correction was practically absent i.e. six hours after inhalation there was 82 and 83% 
retention. In the remaining four patients retention percentages of 56,55,46 and 42% 
were assessed. The mean tracheobronchial retention of all dextrocardia patients was 
significantly larger than the mean retention in ten healthy non-smoking subjects, but 
not significantly different from that of six chronic bronchitics. It is concluded that in 
some patients with dextrocardia, patients with the syndrome of Kartagener included, 
a decreased but effective tracheobronchial clearance exists, which cannot be attrib­
uted to cough alone. 
Finally in chapter Ш a study is described in which the effect of sauna on tracheo­
bronchial clearance in chronic bronchitics has been investigated. Five patients with 
chronic bronchitis took part. Tracheobronchial clearance was measured using the 
radio-aerosol technique described in section 1.4. In a randomized cross-over fashion 
the effect of sauna was compared with a control measurement. Sauna appeared not 
to enhance tracheobronchial clearance. 
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Samenvatting 
In hoofdstuk I wordt een overzicht gegeven van de literatuur betreffende tracheo-
bronchiale klaring. Aspekten zoals struktuur en funktie van het luchtwegepitheel, het 
mucodliair transport en hoesten worden belicht (sectie 1.1). De tracheobronchiale 
klaring in relatie tot diverse longziekten wordt besproken in sectie 1.2. In sectie 13 
worden diverse technieken beschreven, welke in het verleden toegepast zijn om de 
tracheobronchiale klaring te meten. De techniek, welke in ons laboratorium is 
gebruikt wordt beschreven in sectie 1.4. Kort samengevat is het principe van deze 
meting als volgt. Na inhaleren van een radio-aerosol, bestaande uit radioactief 
gelabelde polystyreen partikels, wordt regelmatig de hoeveelheid radioactiviteit in de 
longen gemeten met behulp van twee scintillatie detectoren. De afname van de 
activiteit, na correctie voor verval, achtergrond activiteit en alvéolaire depositie, is een 
maat voor de tracheobronchiale klaring. In deze sectie wordt ook de opzet van het 
onderzoek als geheel uiteen gezet. 
Het eerste onderzoek, beschreven in hoofdstuk Π, betrof het vaststellen van de 
variabiliteit van de tracheobronchiale klaring bij gezonde, niet rokende proefperso­
nen. Om zowel de inter- als intra-individuele variabiliteit te kunnen evalueren werd 
de klaring tweemaal gemeten bij tien vrijwilligers. Voor het meten van de tracheo­
bronchiale klaring werd gebruik gemaakt van de hierboven aangeduide radio-aerosol 
techniek. Verschillende parameters werden gebruikt voor het kwantificeren van de 
meetresultaten. Onder andere werd gekeken naar het oppervlak onder de retentie­
curve vanaf het moment van inhalatie tot 6 uur daarna (AUC-6). De interindividuele 
variatiecoëfficiënt (COV) bij gebruik van deze parameter was 31%. De intra-indivi-
duele COV van de AUC-6 was 11%. Onze resultaten zijn beter dan die gerappor-
teerd door andere onderzoeksgroepen, die gebruik gemaakt hebben van andere 
meettechnieken. Geconcludeerd wordt dat de intra-individuele variabiliteit van de 
tracheobronchiale klaring, zoals gemeten middels deze techniek, gering is. 
In de eerste studie naar het effect van fysiotherapeutische interventies op de tracheo-
bronchiale klaring werden twee vaak toegepaste behandelingstechnieken met elkaar 
vergeleken: conventionele fysiotherapie en geforceerde expiratie techniek (hoofdstuk 
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Ш). Conventionele fysiotherapie omvatte houdingsdrainage, tapotage en hoesten. De 
geforceerde expiratie techniek omvatte ademhalingsoefeningen, huffen, houdings­
drainage en indien nodig, hoesten. Onder huffen wordt verstaan het geforceerde 
uitademen met open stemspleet volgend op een normale inademing. Acht patiënten, 
waarvan zes met mucoviscoidosis en twee met agammaglobulinemie, namen deel aan 
deze studie. Deze twee behandelingstechnieken bleken even effektief wat betreft 
tracheobronchìale klaring, regionale klaring, sputum produktie en longfunktie. Omdat 
de geforceerde expiratietechniek na instruktie en oefening zonder hulp kan worden 
toegepast lijkt deze techniek voor de dagelijkse praktijk de voorkeur te verdienen. 
In hoofdstuk Г worden twee onderzoeken beschreven naar het effekt van behande­
ling met het zogenaamde positieve expiratoire druk (PEP) masker. In een gerando­
miseerde cross-over studie (IV.l) werd het effekt op de tracheobronchìale klaring 
van behandeling met het PEP-masker vergeleken met dat van de geforceerde 
expiratie techniek. Dit onderzoek omvatte tevens een controlemeting. Acht patiënten 
met een chronische bronchitis en overvloedige sputum produktie (gemiddeld 32 gram 
per dag) namen eraan deel. De behandeling met het PEP masker omvatte het 
gebruik van het PEP masker afgewisseld met ademhalingsoefeningen, huffen en 
indien nodig hoesten. Daarbij werd geen houdingsdrainage toegepast. De geforceerde 
expiratie techniek was dezelfde als die beschreven in hoofdstuk Ш. Voor het meten 
van de tracheobronchìale klaring werd gebruik gemaakt van dezelfde radio-aerosol 
techniek als beschreven in sectie 1.4. Veertig minuten na het begin van de behande-
ling was de gemiddelde klaring, uitgedrukt als percentage van de hoeveelheid 
aktiviteit aanwezig bij het begin van de behandeling, 32% na de behandeling met het 
PEP masker, 53% na de geforceerde expiratietechniek en 15% in de controle-meting. 
De verschillen waren statistisch significant (p < 0.02). De sputimi produktie tijdens 
beide behandelingsvormen was significant groter dan tijdens de controlemeting 
(p < 0.02). Geconcludeerd wordt dat beide behandelingsvormen effekt hebben. De 
geforceerde expiratie techniek blijkt echter effektiever dan de behandeling met het 
PEP-masker. In de volgende sectie (IV.2) wordt het effekt van de behandeling met 
het PEP masker op de regionale longklaring beschreven. De regionale longklaring 
werd gemeten met behulp van gamma camera opnames. De resultaten van de behan-
deling met het PEP masker waren niet significant verschillend van die tijdens de 
controle meting. De gemiddelde klaring in alle drie longzônes (perifeer, intermediair 
en centraal) was het grootst na de geforceerde expiratie techniek sessie, welke ook 
houdingsdrainage omvatte. Alleen de klaring na de geforceerde expiratie techniek in 
de centrale zone was statistisch significant (p < 0.02) verschillend van de behandeling 
met het PEP masker en de controle meting. Geconcludeerd wordt dat de behande-
ling met PEP geen aantoonbaar effekt heeft op de regionale klaring. 
In hoofdstuk V wordt het onderzoek beschreven, waarin het effekt van orale hoog-
frekwente oscillatie (OHFO) op de tracheobronchìale klaring is geëvalueerd. OHFO 
werd vergeleken met de geforceerde expiratie techniek en met een controle meting. 
Acht patiënten met chronische bronchitis namen deel aan de studie. De frekwentie, 
waarop OHFO werd toegepast, kwam overeen met de individuele resonantie-
frekwentie van het luchtwegsysteem van de patiënt. OHFO werd gecombineerd met 
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huffen. De geforceerde expiratie techniek was hetzelfde als ш bovenbeschreven 
onderzoeken (hoofdstuk Ш en IV). Ook voor de meting van de tracheobronchiale 
klaring werd gebruik gemaakt van dezelfde radio-aerosol techniek als beschreven in 
sectie 1.4. Zestig minuten na het begin van de behandeling was de gemiddelde 
tracheobronchiale retentie 70 ± 26% na OHFO, 54 ± 26% na de geforceerde 
expiratie techniek en 76 ± 18% in de controle meting, welke alleen huffen omvatte. 
Het effekt van OHFO was niet significant verschillend van dat tijdens de controle. 
Het effekt van de geforceerde expiratie techniek was significant verschillend (p < 
0.02) van dat van OHFO en dat van de controlemeting. Geconcludeerd wordt dat 
OHFO geen effekt heeft op de tracheobronchiale klaring bij patiënten met chroni-
sche bronchitis. 
In hoofdstuk VI wordt het onderzoek beschreven, waarin het effekt op de tracheo-
bronchiale klaring van een geïnhaleerd mucolyticum gecombineerd met de gefor-
ceerde expiratie techniek, werd geëvalueerd. Acht patiënten met chronische bronchi-
tis en overmatige sputum produktie inhaleerden op drie verschillende dagen, waarbij 
de volgorde at random en dubbelblind werd vastgesteld, een van de volgende drie 
vernevelde oplossingen: een oplossing bevattende mercapto-ethaan sulfonzuur 
(MistabronR), een hypertone en een isotone zoutoplossing. Het inhaleren van iedere 
oplossing werd gevolgd door een sessie bestaande uit de geforceerde expiratie 
techniek met houdingsdrainage.De tracheobronchiale klaring werd gemeten met 
behulp van de eerder beschreven radio-aerosol techniek (sectie 1.4). Er werden geen 
significante verschillen in effekt van de drie behandelingen gevonden, zodat geconclu-
deerd kan worden dat MistabronR geen toegevoegde waarde heeft. 
In hoofdstuk VII worden de resultaten van de meting van de tracheobronchiale 
klaring bij zes patiënten met dextrocardie beschreven. De tracheobronchiale klaring 
werd gecorrigeerd voor het effekt van hoesten door de resultaten van de meting van 
de radioaktiviteit in de longen te corrigeren voor de radioaktiviteit gemeten in opge-
hoest sputum. Bij twee patiënten bleek de klaring na toepassing van deze correctie 
nagenoeg afwezig. Er was een retentie van 82 en 83% na 6 uur. Bij de overige vier 
patiënten bedroeg het retentiepercentage 56,55,46 en 42%. De gemiddelde tracheo-
bronchiale retentie van de patiënten met dextrocardie was significant groter dan die 
van tien gezonde niet rokers. De gemiddelde tracheobronchiale retentie van de zes 
dextrocardie patiënten was niet significant verschillend van die bij zes patiënten met 
chronische bronchitis. Kennelijk is er bij sommige patiënten met dextrocardie, 
inclusief patiënten met het syndroom van Kartagener, een effektieve tracheobron-
chiale klaring die niet kan worden toegeschreven aan het effekt van hoesten. 
Tenslotte wordt in hoofdstuk ПІ een onderzoek beschreven waarin het effekt van 
sauna op de tracheobronchiale klaring bij vijf patiënten met chronische bronchitis 
werd bestudeerd. Het effekt van sauna werd vergeleken met een controle meting. 
Er was geen effekt van sauna op de tracheobronchiale klaring aantoonbaar. 
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Nijmegen. In februari 1978 behaalde hij het artsexamen. 
In maart van dat jaar begon de opleiding tot internist in het St. Elisabeth Zieken-
huis te Amersfoort (opleider: Dr. D. Bonte). Na 1 maart 1980 werd deze opleiding 
voortgezet in de Kliniek voor Inwendige Ziekten van het Academisch Ziekenhuis te 
Nijmegen (opleider destijds: Prof.Dr. C.L.H. Majoor, nadien: Prof.Dr. A. van 't 
Laar). Op 1 maart 1983 volgde inschrijving als internist in het spedalistenregister. 
Op 1 januari 1983 werd gestart met de opleiding tot longarts (opleider destijds: Prof. 
CM. Jongerius, nadien Prof.Dr. C.L.A. van Herwaarden). In februari 1985 werd de 
opleiding onderbroken voor de periode van 2 jaar en 8 maanden. De eerste 2 
maanden hiervan werden doorgebracht op het Research Laboratorium (hoofd: Dr. 
D. Pavia, MSc, PhD, IFnst P) van de afdeling 'Thoradc Medicine' (hoofd: Dr. S.W. 
Clarke, MD, FRCP) van het Royal Free Hospital te Londen. 
Gedurende de resterende periode van 2 jaar en 6 maanden lag de nadruk op het 
verrichten van onderzoek, hetgeen uiteindelijk geresulteerd heeft in dit proefschrift. 
Op 1 oktober 1988 werd de opleiding tot longarts officieel hervat. Op 1 september 
1989 volgde de inschrijving als longarts in het spedalistenregister. Tot 1 januari 1990 
was hij werkzaam als longarts op het Universitair Longcentrum Nijmegen, bestaan-
de uit de afdeling Longziekten van het Sint Radboudziekenhuis te Nijmegen en het 
Medisch Centrum Dekkerswald te Groesbeek. Sindsdien is hij als longarts werkzaam 
in het Andreas Ziekenhuis te Amsterdam in assodatie met T.K.G. Deves, longarts. 
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Stellingen bij het proefschrift 
The effect of several physiotherapeutic interventions 
on tracheobronchial clearance' 
door M. van Hengstum 
I 
Het optimale bronchiaaltoilet bestaat uit de geforceerde expiratietechniek in combi-
natie met houdingsdrainage. 
(dit proefschrift) 
II 
In tegenspraak met de theoretische overwegingen hieromtrent heeft het zogenaamde 
PEP-masker geen effect op de klaring in de perifere luchtwegen. 
(dit proefschrift) 
III 
Het inhaleren van een mucolyticum blijkt de tracheobronchiale klaring niet meer te 
bevorderen dan inhalatie van een hypertone of isotone zoutoplossing. 
(dit proefschrift) 
IV 
Orale hoogfrekwente oscillatie blijkt geen aanwinst in de behandeling van patiënten 
met overmatige sputumproduktie. 
(dit proefschrift) 
V 
Sauna mag dan vaak het algemeen welbevinden bevorderen, echter niet de tracheo-
bronchiale klaring. 
(dit proefschrift) 
VI 
Bij patiënten met een kleincellig bronchuscarcinoom, die een respons vertonen op 
chemotherapie, is het voortzetten van de behandeling na zes kuren niet zinvol. 
Spiro SG, Souhami SL. Thorax 1990;45:1. 
νπ 
Bij stervensbegeleiding dient ervoor gewaakt te worden de behandeling van de 
terminale patiënt mede te laten bepalen door onrust, onzekerheid of medelijden 
onder aanwezige naasten. 
ІП 
Het verloop van een bronchoscopie kan in sommige gevallen in gunstige zin worden 
beïnvloed door de patiënt mee te laten kijken bij de inspectie van diens bronchiaal-
boom. 
(eigen waarneming) 
IX 
Twee procent lidocaine spray is voor het verwijderen van exemplaren van de Peripla-
neta Americana uit de gehoorgang meer geschikt dan het gebruik van minerale olie. 
O'Toole К et al. NEJM 1985;312(18):1197. 
X 
De methode gebruikt voor het corrigeren van gietfouten zoals beschreven door 
Cellini (1500-1574), levert een beter resultaat op dan moderne lastechnieken. 
(eigen waarneming) 
XI 
De promovendus dient zelf de stellingen behorend bij zijn proefschrift te bedenken. 
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